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Leukocyte transmigration is a critical step of the inflammatory process.  In this project I 
have examined leukocyte responses to transmigration and endothelial responses to both 
chemical and mechanical stimuli which are known to be involved in leukocyte 
transmigration.  My work has identified ~2500 differentially expressed genes following 
endothelial exposure to interleukin-1 beta (IL1β).  Interestingly, IL1β induces up-
regulation of claudin-1 and pre-b-cell colony enhancing factor and down-regulation of 
claudin-5 and occludin, which are all involved in maintaining endothelial cell-cell 
junctions.  Analysis of endothelial cell (EC) transcriptional changes following 
neutrophil transmigration found few differentially expressed genes in comparison to 
IL1β treated ECs; indicating that the effects of transmigration on ECs are minimal in 
comparison to the global transcriptional changes induced by IL1β.   
 
Atherosclerosis, characterized by monocyte accumulation within the vessel lumen, is 
found in regions of flow reversal and low time averaged oscillatory shear stress.  I have 
examined the effects of this type of shear stress on endothelial cell gene expression.  
My data indicates that most genes differentially expressed under these conditions are 
controlled by low average shear stress rather than flow reversal.  These differentially 
expressed genes are involved in regulating the cell cycle and the immune response.  My 
work shows that cell proliferation is increased following exposure to low steady shear 
stress or exposure to reversing oscillatory flow in comparison to high steady shear 
 
 xviii
stress.  Additionally monocyte adhesion is increased following exposure of ECs to 
reversing oscillatory flow. 
 
My work has also examined the impact of transmigration on monocyte gene expression.  
I have identified genes which are differentially expressed in monocytes by exposure to 
EC secretions, monocyte/EC contact, and diapedesis.  I have also shown that freshly 
isolated human monocytes have reduced apoptosis following transmigration.  
Surprisingly, I also found that monocytes had reduced expression of anti-microbial 
peptides following transmigration.   
 
Overall my work identifies important endothelial and leukocyte transcriptional 
responses to the process of transmigration which extends from cytokine stimulation 








The immune system maintains a variety of innate and adaptive mechanisms in order to 
protect the body from infection as well as to maintain cellular health by removing 
apoptotic and diseased host cells.  One of the first events in the immune response is the 
recruitment of leukocytes to sites of infection or inflammation.  In order for leukocytes to 
migrate out of the vasculature and into surrounding tissues, endothelial cells (ECs) lining 
the vessel lumen must first be stimulated to up-regulate adhesion molecules on the 
endothelial cell surface.  EC stimulation occurs through mechanical and chemical 
mechanisms, often involving cytokine exposure through autocrine, paracrine, and 
endocrine signaling events.   
 
Numerous cytokines function in EC activation, many of which have redundant function.  
Some of the most commonly studied cytokines involved in EC activation include IL1β, 
TNFα, and lipopolysaccharide.  Cytokines interact with ECs by binding to specific cell 
surface receptors, causing intracellular signaling events which can induce transcriptional 
changes, post-translational protein modifications, as well as protein translocation.  Upon 
cytokine stimulation, leukocytes begin to roll along adhesion molecules up-regulated to 
the surface of ECs.  Leukocyte rolling leads to firm adhesion followed by transmigration 
across the endothelium.  This process of EC stimulation and leukocyte transmigration 




I have undertaken the following aims in order to better understand the response of ECs 
and leukocytes to chemical and mechanical stimulation involved in the immune response. 
 
Aim 1:  Analyze Endothelial Cell Responses to IL1β Stimulation and Neutrophil 
Transmigration   
Transcriptional Effects of IL1β Stimulation of Endothelial Cells 
Interleukin-1 is a cytokine whose inflammatory function has been studied since the early 
1980’s.  Many studies over the last thirty years have examined the effects of IL1 on 
endothelial cells.  These studies have primarily examined functional changes in ECs as 
well as changes in RNA and protein levels of individual genes, which could be 
hypothesized based on observed functional differences.  More recently researchers have 
been able to examine the effects of IL1 on a more global scale, using microarrays to test 
for transcriptional changes induced by the cytokine.   
 
Three research groups have published microarray data in which EC were treated with 
IL1β 3-5.  These studies have a number of limitations.  For example, these three studies 
have used microarray platforms which contain probes for 4000 3, 7050 5, and ~18,000 4 
human genes, only representing a fraction of the whole human genome.  Bandman et al. 
and Zhao et al. examined differential gene expression in response to both IL1β and TNFα 
and have reported them in a single list, making analysis of individual effects of IL1β 
difficult.  In addition, all three of these groups used very stringent statistical analysis 
techniques such that all together these three groups reported only 377 genes which were 
differentially expressed by IL1β stimulation of HUVEC.  In my work, I have used a 
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whole human genome microarray to analyze expression of ~40,000 RNA sequences in 
combination with less stringent statistical techniques.  This allowed me to identify over 
2500 differentially expressed genes following IL1β treatment of HUVEC.  In my work I 
have used qRT-PCR and western blotting to further verify differential expression of 
specific genes relevant to leukocyte transmigration.   
 
Impact of Neutrophils on Endothelial Cells  
Neutrophil transmigration occurs in a series of stages in which neutrophils first begin to 
roll along stimulated endothelium.  They then firmly adhere and finally begin to 
transmigrate across the endothelium.  Direct cell-cell contact between ECs and 
neutrophils as well as cytokine release from the neutrophils may cause changes in EC 
function.   
 
A number of groups have examined the impact of leukocyte firm adhesion on endothelial 
cell function (Reviewed by Van Buul et al. 6).  Neutrophil firm adhesion is mediated 
primarily by integrin binding of ICAM1 and VCAM1 on the endothelial surface.  In early 
work, Etienne et al. examined the impact of ICAM1 cross-linking on EC tight junction 
molecules 7.  This group showed that three proteins which localize at focal adhesions 
(focal adhesion kinase, paxillin, and p130CAS) exhibited increased tyrosine 
phosphorylation after ICAM1 cross-linking.  van Wetering et al. performed similar 
experiments to examine the impact of VCAM1 cross-linking.  VCAM1 cross-linking was 
shown to induce intercellular gaps as well as stress fiber formation.  VCAM1 cross-
linking activates cell-signaling molecules as evidenced by Rac activation and increased 
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phosphorylation of p38 MAPK.   Inhibition of Rac was also shown to cause a decrease in 
transmigration of a monocytic cell line across IL1β treated HUVEC in response to the 
chemokine C5a.   
 
Other studies have more directly investigated the impact of neutrophils on EC function.  
Huang et al. showed that transmigration of neutrophils in response to the cytokine FMLP 
caused a 5 to 8 fold increase in cytosolic Ca levels of HUVEC 8.  These high ratios of 
neutrophil transmigration ensured that almost every EC had been involved in at least one 
neutrophil transmigration event.  Increased cytosolic Ca levels were not seen in the 
presence of neutrophils without the addition of FMLP or in the presence of FMLP alone.  
This indicates that the transmigration process itself or possibly the induction of cytokine 
release from neutrophils as stimulated by FMLP causes an increase in EC cytosolic Ca 
levels.  Changes in cytosolic Ca have been linked to a number of cell signaling events 
which can cause eventual changes in transcription as well as protein expression 9. 
 
Marcus et al. examined the impact of neutrophil contact versus neutrophil cytokine 
release on the transendothelial electrical resistance (TEER) of an endothelial cell layer 10.  
This group showed that direct contact of ECs with neutrophils caused a drop in the TEER.  
However, the incubation of neutrophils with ECs without allowing neutrophils to actually 
contact the ECs did not elicit the same response.  This study indicates that cell-cell 
contact between ECs and neutrophils can elicit changes within the EC.  This EC response 
to neutrophil contact may allow for increased neutrophil transmigration by reducing EC 




A more recent study by Cepinskas et al. examined the effect of neutrophil transmigration 
on nuclear NFκb levels within ECs 11.  Neutrophil transmigration resulted in a dose 
dependent reduction of nuclear NFκb levels.  When neutrophil adhesion and 
transmigration were blocked via CD18 blocking antibodies, this reduction in nuclear 
NFκb levels was not seen.  Nuclear localization of NFκb has been closely tied to IL1β 
stimulation in HUVEC 12.  Nuclear localization of NFκb has been shown to cause up-
regulation of a number of adhesion molecules as well as stimulation of cytokine 
production  and transcriptional changes 13.  Thus, Cepinskas et al. have provided evidence 
that neutrophil transmigration may act as negative feedback in order to reduce neutrophil 
transmigration once it has already occurred.  
 
Previous studies provide substantial evidence that neutrophil transmigration does indeed 
affect EC function.  To date none of these studies have shown a direct impact on EC 
transcription. My work examines how neutrophil transmigration specifically affects EC 
gene expression.  My data indicate that the transcriptional effects of neutrophil 
transmigration are far overshadowed by the EC transcriptional response to IL1β. 
 
Aim 2:  Analysis of Monocyte Responses to Transmigration across Stimulated 
HUVEC 
Atherosclerosis is an extremely common disease characterized by plaque formation 
within the arteries.  Rupture of an atherosclerotic plaque can cause myocardial infarctions, 
strokes, aneurysms, as well as many other serious conditions.  Atherosclerotic plaque 
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formation begins with up-regulation of adhesion molecule expression on the vascular 
endothelium 14.  The stimulus which causes this up-regulation is currently under a great 
deal of debate.  Many researchers have hypothesized that the accumulation of lipids 
within the intima may lead to lipid oxidation which then leads to EC stimulation.  
Interestingly, this increased adhesion molecule expression associated with the initial 
stages of atherosclerosis is primarily located at branching points within the arteries which 
experience disturbed blood flow patterns 15.  Thus it is also suggested that mechanical 
stimulation of ECs may lead to increased or decreased atheroprotective mechanisms as 
well as altered adhesion molecule expression.  
 
Upon exposure to EC adhesion molecules, leukocytes become adherent and begin to 
penetrate into the intima.  As monocytes enter the atherosclerotic plaque, these cells 
begin to differentiate into macrophages.  Macrophages express scavenger receptors for 
lipoproteins, thus allowing them to ingest lipids and become foam cells 16.  Macrophages 
also express increased levels of toll-like receptors which have been linked to down 
stream secretion of pro-inflammatory cytokines and matrix metalloproteinases (MMPs) 17.  
MMPs are of particular importance because these proteolytic enzymes may play a role in 
degradation of the fibrous cap which protects the plaque from rupture 18.  Since many of 
the most life-threatening clinical events are related to plaque rupture, plaque stabilization 
is especially important for developing clinically relevant therapies.   
 
Monocytes play an extremely important role in atherosclerotic plaque formation and 
rupture.  Thus, it is important to understand the changes which occur within monocytes 
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during this process.  In 1999, Hashimoto et al. used serial analysis of gene expression to 
investigate transcriptional differences between monocytes and monocyte derived 
macrophages 19.  In this study, monocyte derived macrophages were obtained by 
incubating fresh monocytes with either granulocyte-macrophage colony-stimulating 
factor (GM-CSF) or macrophage colony-stimulating factor (M-CSF) for seven days.  
Over 300 differentially expressed genes were identified following GM-CSF or M-CSF 
treatment.  A number of the up-regulated genes, such as apolipoproteinE, osteopontin, 
CD9, and lysosomal acid lipase, were associated with proteins involved in lipid 
metabolism.  This suggests that development of the lipid metabolism system may be 
important for macrophage differentiation and thus links macrophages even more closely 
with atherosclerosis.   
 
Li et al. used cDNA microarrays to examine differences between monocytes, monocyte-
derived macrophages via M-CSF, and primary human alveolar macrophages 20.  Some of 
the most highly down-regulated genes in this study are involved in important intracellular 
signaling pathways.  Similar to previously described data from Hashimoto et al. 19, some 
of the most highly up-regulated genes in macrophages were associated with lipid 
metabolism, e.g. fatty acid binding protein 4, fatty acid binding protein 5, and lipoprotein 
lipase.  This group also found a number of differences in gene expression levels between 
macrophages derived in vitro via M-CSF and human alveolar macrophages.  These 
differences indicate that in vivo macrophages could be very heterogeneous, depending 




These studies have examined gene expression levels in mature macrophages obtained 
from alveoli or from in vitro cultivation methods.  Comparison to freshly isolated 
monocytes is important for discovering modes of differentiation and functional 
capabilities of macrophages compared to monocytes.  However, none of these studies 
have examined monocytes at very early stages of macrophage differentiation.  Monocytes 
may begin the process of differentiation during the initial stages of cytokine stimulation 
and interaction with the endothelium.  In particular, the process of monocyte 
transmigration may greatly impact monocyte gene expression.   
 
My work examines differential gene expression in monocytes which have transmigrated 
across the endothelium as compared to freshly isolated monocytes.  Use of careful 
controls has allowed for determination of specific transcriptional effects induced by 
monocyte exposure to secretions from stimulated ECs, monocyte/endothelial cell contact, 
and monocyte diapedesis. 
 
Aim 3:  Impacts of Reversing Flow Patterns on HUVEC Inflammation and 
Monocyte Transmigration  
Atherosclerosis primarily occurs within the large and medium sized arteries and develops 
at specific regions of the vasculature which are characterized by low shear stress, 
oscillatory flow, or turbulent flow patterns 21.  These disturbed blood flow patterns occur 
most often at branching points and the inner wall of vessel curvatures 22.  Endothelial 
cells act as one of the primary cell types to sense mechanical forces within the 
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vasculature.  Thus, a number of researchers have examined transcriptional changes in 
ECs in response to various types of hemodynamic forces 23-27.   
 
My work examines differential gene expression in ECs following exposure to reversing 
oscillatory shear stress modeled after the wall shear stress found at the carotid sinus.  Use 
of a low shear stress control has allowed for identification of genes regulated by low time 
average shear stress and genes regulated by flow reversal.  I have also examined 
monocyte adhesion following EC exposure to reversing flow. 
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CHAPTER 2:  GENE EXPRESSION OF ENDOTHELIAL CELLS DUE TO 





N.B.  This chapter is published (Marcie R. Williams, Noriyuki Kataoka, Yumiko Sakurai, 
Christina M. Powers, Suzanne G. Eskin, and Larry V. McIntire.  Endothelium. 
2008;15:73-165.). 
 
To reach a site of infection, neutrophils must move out of the blood vessels and into the 
surrounding tissue.  The initial event in this inflammation cascade is the activation of ECs.  
Cytokines, such as interleukin-1 beta (IL1β) and tumor necrosis factor α (TNFα), are key 
mediators in stimulating ECs at sites of inflammation.  EC activation by cytokines is 
characterized by release of chemokines 28, expression of adhesion molecules on the 
endothelial cell surface 29, alteration of endothelial cell shape 30 and alteration of 
cytoskeletal distribution 31.  These responses to cytokine stimulation facilitate neutrophil 
adhesion to ECs and transendothelial migration. 
 
Leukocyte emigration is classified into three steps, i.e. rolling, firm adhesion and 
migration 32.  These steps involve a number of different types of molecules and signaling 
events within the ECs 8,33-37.  Despite the fact that many adhesion molecules have been 
studied, new adhesion molecules implicated in leukocyte migration are still being 
identified 38-40.  Moreover, new steps other than rolling, firm adhesion and migration, 
have also been proposed 41.  To understand the process of inflammation, we need to 
elucidate cellular responses, i.e., gene and protein expression in both ECs and neutrophils, 
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signal transduction within and between ECs and neutrophils, adhesion molecule 
expression, and cellular behavior. Changes in gene expression occur during the initial 
phase of the cellular response, thus making gene expression analysis relevant for 
understanding this process.  However, currently there is little known about changes in EC 
gene expression due to neutrophil transmigration. 
 
DNA microarrays are a powerful screening tool for identifying genes which are 
differentially expressed following cellular exposure to various stimuli.  Our own lab has 
used this technique to analyze the gene expression of ECs in response to mechanical 
forces 23,26,42.  Several DNA microarray studies have also examined the effect of 
inflammatory stimuli on EC transcription 3-5. These studies identified approximately 350 
genes which are differentially regulated by IL1β, or IL1β and TNFα.  We hypothesized 
that transmigration of neutrophils through an activated EC monolayer would stimulate 
further transcriptional changes in the ECs.  To elucidate the role of neutrophil 
transmigration we compared gene expression in IL1β stimulated ECs to gene expression 
in IL1β stimulated ECs following neutrophil transmigration. 
 
Materials and Methods 
Cell culture and materials 
 Pooled human umbilical vein endothelial cells (HUVEC) were purchased from 
Lonza.  EGM-2 media was made from EBM-2 media (Lonza) with the addition of an 
EGM-2 bullet kit (Lonza) containing 2% fetal bovine serum, gentamicin sulfate, 
amphotericin, vascular endothelial growth factor, recombinant human fibroblast growth 
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factor basic, ascorbic acid, R3 insulin-like growth factor 1, hydrocortisone, heparin, and 
recombinant human epidermal growth factor.  For microarray experiments, passage 3-4 
HUVEC were seeded at 50,000 cells/cm2 onto fibronectin coated (2.5μg/cm2) six well 
polyethylene terephthalate (PET) membrane cell culture inserts (diameter = 23mm) 
containing 3 μm pores (BD Falcon) and cultured in EGM-2 until confluent at 37 oC in the 
presence of humidified 5% CO2.  HUVEC used in time course experiments were cultured 
in supplemented M199 (Mediatech) containing 20% fetal bovine serum (Hyclone), 50 
U/mL penicillin (Gibco), 50 μg/ml streptomycin (Gibco), 2mM L-glutamine (Mediatech), 
2.5 U/ml heparin (American Pharmaceutical Partners), and 50 μg/ml endothelial mitogen 
(Biomedical Technologies).   
 
Isolation of neutrophils 
Human neutrophils were isolated from whole blood obtained from healthy adult donors 
after obtaining informed consent 43.  Briefly, whole blood was drawn into citrate buffer 
anticoagulant and red blood cells were allowed to settle out in a 6% Dextran 70 solution 
(B. Braun).  Red blood cells remaining in the supernatant were lysed with a 0.2% NaCl 
solution for 20 seconds.  Cells were centrifuged over a layer of lymphocyte separation 
media (1.078 g/mL, Cellgro) and pellets were resuspended in MEM with 0.5% human 
serum albumin (National Hospital Specialties).  Isolated neutrophils were maintained in 
MEM with 0.5% human serum albumin at 37 oC until application to HUVECs and used 
within four hours after isolation.   
 
Microarray experimental protocol 
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HUVEC treatment was begun approximately 24 hours after the cells reached confluence, 
at which time the media was replaced with EGM-2 media containing 100 pg/ml IL1β.  
Four hours later, the media was replaced with MEM containing 0.5% human serum 
albumin (HSA) and 100 pg/mL IL1β.  In some conditions, 1 million freshly isolated 
neutrophils were applied.  Neutrophil treatment and further IL1β stimulation was 
performed for 1 hours or 3 hours, as shown in Figure 1.  Control and control + MACS 




Figure 1:  Experimental Conditions.   
“Control” samples were cultured on cell culture inserts in EGM-2, trypsinized, pelleted, and lysed for RNA 
isolation. “Control + MACS” samples were treated similarly with an additional step of anti-CD45 MACS 
purification. “IL1β 5 h” samples were treated with 100 pg/mL IL1β in EGM-2 for 4 h, then with 100 
pg/mL IL1β in MEM + 0.5% HSA for 1 h, and followed up with anti-CD45 MACS purification. “IL1β 7 
h” samples were treated similarly except that the final IL1β treatment in MEM + 0.5% HSA was performed 
for 3 h. Comparison of “IL1β 5 h” and “IL1β 7 h” to “Control + MACS” allows determination of the 
effects of IL1β. “IL1β 5 h + Neutrophils 1 h” samples were treated with 100 pg/mL IL1β in EGM-2 for 4 h 
followed by the addition of 1 million neutrophils in MEM + 0.5% HSA containing 100 pg/mL IL1β for 1 
h. Anti-CD45 MACS purification was used to remove contaminating neutrophils from the HUVEC 
samples prior to cell lysis for RNA isolation. “IL1β+Neutrophils 3 h” samples were treated similarly 
except that neutrophils were applied for 3 h. 
 
 
Effect of MACS 
Effects of IL1β 
Effects of IL1β 
Effect of Neutrophils 
Effect of Neutrophils 
Control Control + MACS
IL1β 5 h IL1β 5 h + Neutrophils 1 h
IL1β 7 h IL1β 7 h + Neutrophils 3 h
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Transmigrated neutrophils were collected from beneath cell culture inserts and counted 
with a Beckman Coulter Z2 Particle Count and Size Analyzer to determine percent 
transmigration.  To obtain RNA from HUVEC after neutrophil transmigration, it was first 
necessary to magnetically remove neutrophils which remained adherent to the HUVEC.  
Cells were tryspinized off the cell culture inserts, and were incubated with CD45 
Microbeads (Miltenyi) for 15 minutes at 4 oC.  Neutrophils were removed from HUVEC 
by passing the cell mixture over a MS column placed in a miniMACS Magnetic 
Separator (Miltenyi).  HUVEC were collected in the flow-through from the magnetic 
column.  This step, in which CD45 antibodies were used to remove neutrophils, was 
applied to all conditions except the control in order to account for any differential gene 
expression which might be induced by magnetic cell sorting.  RNA was isolated for each 
of 6 conditions a total of three times from three different blood donors.  
 
In some studies performed subsequent to microarray analysis anti-glycophorin A 
magnetic beads were used to remove contaminating red blood cells (RBCs) and 
reticulocytes prior to RNA isolation.  These beads were used to purify neutrophils prior 
to addition to ECs or to purify trypsinized ECs just prior to RNA isolation.   
 
Time course experimental protocol 
HUVEC were cultured on 75 mm tissue culture inserts in supplemented M199 media 
until confluent.  Approximately 24 hours after the cells reached confluence, the media 
was replaced with supplemented M199 containing 100 pg/ml IL1β for either 0, 5, 7, 12, 
or 24 hours.  HUVEC were trypsinized off the cell culture inserts and lysed with either 
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M-PER (Pierce) or Buffer RLT (Agilent) for the collection of either protein or RNA, 
respectively.  This experimental protocol was repeated 7 times with separate HUVEC lots. 
 
RNA isolation 
RNA was isolated from purified HUVEC with an RNEasy Micro Kit (Qiagen), according 
to the manufacturer’s instructions.  RNA quantity and quality were assessed by loading 1 
μl of sample RNA onto a RNA 6000 Nano chip (Agilent) and analyzing with an Agilent 
2100 Bioanalyzer to determine the amount and integrity of RNA recovered (Table 1).  
RNA Integrity Scores can range from 0 to 10 with 10 indicating the highest quality of 
RNA. 
 
Table 1:  Average RNA amounts and RNA Integrity Numbers. 
Treatment RNA Amount (μg)* RNA Integrity Number* 
Control 7.4 +/- 2.4 9.9 +/- 0.03 
Control + MACS  6.8 +/- 0.6 9.4 +/- 0.4 
IL1β 5 h 8.1 +/- 2.0 9.9 +/- 0.1 
IL1β 5 h + Neutrophils 1 h  8.1 +/- 2.4 9.9 +/- 0.05 
IL1β 7 h 7.9 +/- 2.3 9.9 +/- 0.05 
IL1β 7 h + Neutrophils 3 h 5.7 +/- 1.2 9.9 +/- 0.03 




Microarray hybridization and imaging were performed at the Morehouse School of 
Medicine Functional Genomics Core Facility.  Briefly, RNA and Universal Human 
Reference RNA (Stratagene) were linearly amplified to cRNA using a Low RNA Input 
Fluorescent Linear Amplification Kit (Agilent) according to the manufacturer’s 
instructions.  Cy5-labeled cRNA for each sample was competitively hybridized with 
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Cy3-labeled reference cRNA to a 44k Whole Human Genome Microarray (Agilent) 
according to the manufacturer’s instructions.  Slides were dried under nitrogen and 
scanned on an Agilent DNA Microarray Scanner.  Microarray images were analyzed with 
Agilent Feature Extraction Software according to the manufacturer’s instructions.   
GeneSpring software was used to further analyze the microarray data.  One way ANOVA 
assuming equal variances was applied using Benjamini and Hochberg multiple testing 
correction at a false discovery rate of 5%.  Differentially expressed genes were identified 
as those genes which had fold changes of at least 1.5 fold and adjusted p-values of less 
than 0.05.   
 
A list of differentially expressed genes was uploaded to the Database for Annotation, 
Visualization and Integrated Discovery (DAVID) and subjected to Functional Annotation 
Clustering at Medium Class Stringency in order to identify enriched biological themes 44.  
Gene Ontology (GO) Biological Process annotations were used to perform this functional 
clustering.  Clusters which had an enrichment score greater than 1.5 and specific gene 
functions were identified.  Lists of up-regulated and down-regulated genes were uploaded 
separately to DAVID in order to identify enriched KEGG Pathways and map 
differentially expressed genes to these pathways. 
 
Quantitative Real Time PCR 
1 μg of total RNA from each sample was reverse transcribed into cDNA using 
SuperScript II (Invitrogen).  cDNA was purified with Micro Bio-Spin P-30 
Chromatography Columns (BioRad), and diluted in RT-PCR Grade Water (Ambion) 1:80.  
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Pre-designed PCR primers and Quantitect SYBR Green PCR Master Mix were purchased 
from Qiagen.  Primers were added to the master mix at a ratio of 1:5.  Each reaction was 
performed with 4 μl of diluted cDNA and 6 μl of primers in the master mix.  The qRT-
PCR reactions were performed on a LightCycler 2.0 (Roche Applied Science) with a 15 
minute activation step at 95 oC; 50 cycles at 94 oC for 15 seconds, 55 oC for 20 seconds, 
72 oC for 20 seconds; and a ramped melting cycle.  Fold changes were determined using 
the ΔΔCt method.  Statistical differences between ΔCts were assessed using a paired 
Student’s t-test.  qRT-PCR was used to verify gene expression from RNA isolated from 
three microarray experiments.  RNA from seven time course experiments was used to 
examine the temporal effects of IL1β.  
  
Western blots  
Protein (65 μg) was resolved by SDS-PAGE in 10% Tris-HCL precast polyacrylamide 
gels (Bio-Rad) with Laemmli sample buffer and electro-transferred onto PVDF 
membranes (Hybond-P, GE Bioscience).  After blocking with 5% nonfat dry milk, 
membranes were probed with rabbit polyclonal claudin-1 antibodies (Zymed), mouse 
monoclonal claudin-5 antibodies (Zymed), goat polyclonal PBEF antibodies (Santa Cruz), 
and mouse monoclonal β-actin antibodies (Sigma).  Bound primary antibodies were 
labeled with horseradish peroxidase conjugated secondary antibodies and detected with 
enhanced chemiluminescence (ECL Plus, Amersham Biosciences).  Band densities were 
quantified by densitometry with the Kodak EDAS 1D Imaging System (Kodak).  Western 
blots were performed using protein isolated from 6 separate time course experiments and 






The percentage of neutrophils which transmigrated was quantified after 1 and 3 hours of 
neutrophil application by counting the number of neutrophils collected from beneath the 
cell culture inserts (Figure 2).  After one hour, 8 +/- 4 %, and after three hours, 35 +/- 3%, 
of the applied neutrophils had transmigrated (n=3).   
 




























Figure 2:   Neutrophil percent transmigration.   
1 million neutrophils in MEM + 0.5% HSA were applied to IL1β stimulated HUVEC grown on a cell 
culture insert.  Neutrophils were allowed to transmigrate across the activated HUVEC for either 1 hour or 3 
hours.  Transmigrated neutrophils were collected from the cell culture dish beneath the HUVEC and 
counted.  The percentage of transmigrated neutrophils was calculated as the number of neutrophils 
collected below the HUVEC divided by the number of neutrophils applied to the HUVEC.    *P<0.05 
versus 1 hour transmigration.  n = 3 
 
 
Following neutrophil transmigration, unmigrated neutrophils were rinsed off the HUVEC 
layer; however, some of the applied neutrophils remained adherent to the HUVEC.  The 
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HUVEC were trypsinized and contaminating neutrophils removed using CD45 
Microbeads prior to isolating HUVEC RNA.  RNA was collected from HUVEC under 
six different treatment conditions.  Table 1 (page 15) shows the quantity and quality of 
RNA collected from all conditions, with high average RNA integrity scores as assessed 
by the Agilent Bioanalyzer.   
 
Microarray condition tree 
Microarray data were analyzed using a Pearson Correlation to generate a condition tree, 
which indicates that gene expression in HUVEC treated with IL1β alone (Figure 3, 
columns 3 & 5) is very similar to gene expression in HUVEC exposed to neutrophil 
transmigration and treated with IL1β for the same total time (Figure 3, columns 4 & 6).  
HUVEC treated with the MACS system without IL1β clustered with untreated HUVEC, 
indicating that the MACS system had negligible impact on gene expression (Figure 3, 
columns 1-2).  All samples treated with IL1β clustered on a separate branch from cells 
not treated with IL1β.  A comparison of the 5 hour IL1β treatment (Figure 3, columns 3-
4) to the 7 hour IL1β treatment (Figure 3, columns 5-6) reveals the transient nature of 
IL1β stimulation, as there are several groups of genes which are differentially expressed 




Figure 3:  Condition tree. 
A condition tree was generated using Genespring GX 7.3.1 to cluster microarray data based on Pearson’s 
correlation.  Red indicates 1.5 fold or greater up-regulation in comparison to the median expression level 
for each gene in the control samples, blue indicates 1.5 fold or greater down-regulation, and yellow 
represents genes which did not change expression level.  This condition tree separates the 6 conditions of 
this experiment into two branches.  The branch on the left contains the conditions which were not treated 
with IL1β.  The branch on the right contains conditions which were treated with IL1β.  IL1β treated 
samples also branched according to the length of time the HUVEC were treated with IL1β.  This condition 
tree indicates that the primary effector of differential gene expression in this experiment is IL1β with 





















































IL1β treatment effects 
Analysis of microarray data identified 2716 genes and 2972 genes as being differentially 
expressed following 5 or 7 hours of IL1β stimulation, respectively relative to control + 
MACS (Supplemental Table 1).  DAVID was used to functionally group these 
differentially expressed genes according to Gene Ontology: Biological Processes.   This 
analysis revealed functional groups of genes associated with apoptosis, cell cycle, NF-κB 
cascade, chemotaxis, immune response, proteoglycan metabolism, chromosome 
organization and biogenesis, angiogenesis, and hemopoiesis.  Table 2 lists these 
functional groups along with their annotation cluster enrichment score which is used to 
rank these functional groups according to biological significance.   
 
Table 2:  Functional Clustering. 
Functional Annotation Cluster Enrichment Score 
Apoptosis 6.36 
Cell Cycle 4.59 
NF-κB Cascade 4.47 
Chemotaxis 3.75 
Immune Response 3.64 
Proteoglycan Metabolism 1.98 





Using DAVID we also identified KEGG pathways containing a significant number of 
genes which are differentially expressed by IL1β.  Pathways enriched with up-regulated 
genes include Cytokine-Cytokine Receptor Interaction, MAPK Signaling, Cell Adhesion 
Molecules, JAK-STAT Signaling, Toll-Like Receptor Signaling, Apoptosis, Epithelial 
Cell Signaling in Helicobacter Pylori Infection, Antigen Processing and Presentation, 
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Adipocytokine Signaling, TGF-Beta Signaling, T Cell Receptor Signaling, and Type I 
Diabetes Mellitus.  Pathways enriched with down-regulated genes include WNT 
Signaling, Purine Metabolism, and Tight Junctions.  Up and down-regulated genes are 
overlayed on the Cytokine-Cytokine Receptor Interaction pathway in Figure 4.  Genes 
within this pathway are divided into chemokines, hematopoetins, PDGF family, 
interferon family, IL10 family, TNF family, TGFβ family, IL17 family, and IL1 family.  
Thirteen chemokine ligands were up-regulated by IL1β while one chemokine ligand and 
one chemokine receptor were down-regulated by IL1β.  Chemokine ligands attract 
leukocytes to sites of infection through interaction with chemokine receptors and 
establishment of a chemokine gradient.  Overall, thirty cytokine ligands were up-
regulated by IL1β and 5 ligands were down-regulated.  In addition, fourteen cytokine 
receptors were up-regulated by IL1β and 6 receptors were down-regulated.  Mapping 
differentially expressed genes to the cytokine-cytokine receptor pathway offers a visual 
image of the important role IL1β plays in leukocyte recruitment, hematopoiesis, and 
other inflammatory processes.  Overlays of differentially expressed genes within the 
Apoptosis and MAPK signaling pathways are shown in Supplemental Figures 1 and 2 
respectively. (All supplemental figures and tables are located on included CD.)   
 
Comparison of our data with other microarray studies on IL1β stimulated HUVEC 
revealed similar patterns of expression.  There were 6 genes which were shown to be 
differentially expressed by three previous microarray studies.  Our microarray data 
confirmed 100% of these genes, as shown in Table 3, in which fold changes are 










































































































































































































shown to be differentially expressed in two of the three previous microarray studies of 
IL1β stimulated HUVEC and our data confirmed 81% of these genes (Supplemental 
Table 2).  Finally, there were 324 genes which were shown by only one of the previous 
studies to be differentially expressed by IL1β treated HUVEC.  Our microarray data 
confirmed differential expression at either 5 or 7 hours of IL1β treatment for 46% of 
these genes (Supplemental Table 3).   




IL1β 5 hours + 
Neutrophils 1 hour 
Fold Change 
IL1β 7 hours 
Fold Change 
IL1β 7 hours + 
Neutrophils 3 hours 
Fold Change 
Interleukin 8 IL8 109 113 99 98 
E-selectin  SELE 57 64 60 56 
Cyclooxygenase 2 COX2 49 58 35 34 
Vascular Cell 
Adhesion molecule 1 VCAM1 13 11 9 9 
Ubiquitin D UBD 14 15 14 15 
Fractalkine CX3CL1 19 20 12 11 
 
qRT-PCR was used to confirm differential expression of 4 genes which had not been 
previously described as being affected by IL1β treatment in HUVEC microarray 
literature.  These genes were chosen for qRT-PCR verification based on their known 
functions as cytokines and cell structural components.  Table 4 contains a list of verified 
genes along with fold changes as determined by both microarray and qRT-PCR.  Of 
particular interest were claudin-1, claudin-5, and occludin which are all tight junction 
associated molecules.  Fold changes determined by qRT-PCR confirmed either up-
regulation or down-regulation as found in the microarray results, with results from qRT-
PCR showing larger fold changes.     
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Table 4:  Comparison of microarray and qRT-PCR findings. 
Gene Method 5 Hour Fold 
Change 
7 Hour Fold 
Change 
Claudin-1 Microarray 2.8x 3.8x 
Claudin-1 PCR 23.5 +/- 7.7* 47.8 +/- 34.2 
PBEF Microarray 7.2x 3.9x 
PBEF PCR 8.9 +/- 1.8* 4.8 +/- 0.6* 
Claudin-5 Microarray 0.41x 0.49x 
Claudin-5 PCR 0.24 +/- 0.04* 0.25 +/- 0.04* 
Occludin Microarray 0.38x 0.39x 
Occludin PCR 0.10 +/- 0.01* 0.19 +/- 0.03* 
*Fold changes calculated versus control + MACS, p <0.05 n=3 
 
 
Time course analysis of IL1β effects 
To further analyze the impact of IL1β on endothelial cells, a time course of IL1β 
treatment was performed.  Endothelial cells were treated with 100 pg/ml IL1β for either 0, 
5, 7, 12, or 24 hours.  mRNA levels were examined for claudin-1, claudin-5, occludin, 
and PBEF using qRT-PCR.  Claudin-1 is up-regulated 32 +/- 18 fold following 7 hours of 
IL1β treatment, with expression returning to basal levels after 24 hours of HUVEC 
exposure to IL1β (Figure 5).  PBEF up-regulation peaks at 5.2 +/- 1.5 fold after 5 hours 
of IL1β treatment with PBEF mRNA levels returning to original levels after 24 hours of 
IL1β exposure (Figure 6).  Both claudin-5 and occludin mRNA are down-regulated in 
IL1β stimulated HUVEC, with maximum down-regulation  occurring at 0.37 +/- 0.07 and 
































Figure 5:   Claudin-1 mRNA fold change as a function of IL1β treatment time.   
Confluent HUVEC were treated with 100 pg/ml IL1β for either 0, 5, 7, 12, or 24 hours.  qRT-PCR was 
used to quantify mRNA expression of claudin-1.  Fold changes were obtained by normalizing all 
expression levels to expression levels at the 0 hour time point.  Claudin-1 mRNA is up-regulated 32 fold 
after 7 hours of IL1β treatment with an approximate 30x fold change in comparison to untreated HUVEC.  
After 24 hours of IL1β treatment, mRNA expression of claudin-1 returned to its original value.  *p<0.05 
versus 0 hours of IL1β treatment.  n = 4-7 
 
 


































Figure 6:  PBEF, occludin, and claudin-5 mRNA expression as a function of IL1β treatment time.   
Confluent HUVEC were treated with IL1β for either 0, 5, 7, 12, or 24 hours.  qRT-PCR was used to 
quantify mRNA expression of PBEF, occludin, and claudin-5.  Fold changes were obtained by normalizing 
all expression levels to expression levels at the 0 hour time point.  PBEF mRNA is up-regulated 5 fold after 
5 hours of IL1β treatment with mRNA expression returning to original levels after 24 hours of IL1β 
treatment.  Occludin and claudin-5 experienced peak down-regulation after 5 hours of IL1β treatment with 
expression levels returning to original values after 24 hours of IL1β.  *p<0.05 versus 0 hours of IL1β 




Western blotting verification of IL1β effects 
To better understand the functional changes in HUVEC after IL1β treatment, we 
examined protein expression of claudin-1, claudin-5, and PBEF.  Western blot analysis 
was performed on protein isolated from HUVEC after 0, 5, 7, 12, or 24 hours of 
treatment with IL1β (Figure 7). Fold changes in protein expression of these genes closely 
follows fold changes seen in mRNA expression.   
 































Figure 7:  Protein expression fold changes for claudin-1, PBEF, and claudin-5 as a function of IL1β 
treatment time.   
Band densities were quantified by densitometry with the Kodak EDAS 1D Imaging System and normalized 
to β-actin expression levels.  Claudin-1 and PBEF protein levels remain elevated (1.5-2 fold) following 5 
hours of IL1β stimulation and throughout the rest of the 24 hour time course.  Claudin-5 protein expression 
was maximally down-regulated at 7 hours of IL1β treatment and then returns to original levels after 24 
hours of IL1β.   *p<0.05 versus 0 hours of IL1β treatment. n = 6 
 
Neutrophil transmigration effects on EC gene expression 
After allowing neutrophils to transmigrate in the presence of IL1β for one hour (with 
previous IL1β treatment for 4 hours), 19 genes were differentially expressed with fold 
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changes greater than 1.5 as compared to IL1β treatment alone for 5 hours .  After three 
hours of neutrophil transmigration, 22 genes were differentially expressed with fold 
changes greater than 1.5 versus IL1β treatment for 7 hours.  Table 5 contains a list of fold 
changes for differentially expressed genes in IL1β treated HUVEC after neutrophil 
transmigration as compared to IL1β treatment alone.  Fold changes represented by dashes 
(--) indicate that these genes were not differentially regulated by neutrophil 
transmigration at the indicated time point.   At both one and three hours of transmigration, 
hemoglobin beta (HBB) was the most highly up-regulated gene.   
Differential expression of HBB following neutrophil transmigration was confirmed using 
qRT-PCR.   qRT-PCR revealed no gene expression of HBB prior to neutrophil 
transmigration; however, expression of HBB could be detected following neutrophil 
transmigration.  After neutrophil transmigration, the ECs were trypsinized and purified 
using anti-CD45 magnetic beads to remove contaminating neutrophils.  Because HBB 
protein is a component of hemoglobin in red blood cells, we investigated the possibility 
that HBB gene expression was derived from red blood cell contamination of the 
neutrophils.  Red blood cells do not express CD45 and therefore would not bind to anti-
CD45 magnetic beads.  Thus some RBCs found in the neutrophil population would not 
be removed from the trypsinized ECs following purification with anti-CD45 magnetic 
beads.  Mature RBCs do not contain mRNA; however, reticulocytes, immature red blood 
cells which make up about 1% of the total red blood cell population, do contain mRNA.  
Therefore, a small population of reticulocytes may be responsible for the HBB gene 




Table 5:  Differentially expressed genes following neutrophil transmigration. 
Gene ID Gene Name 
IL1β 5 hours 
+ 
Neutrophils 








NM_000518 hemoglobin, beta 5.647 4.009 
NM_000359 transglutaminase 1  1.928  -- 
AF216583 Unannotated 1.671  -- 
XM_059318 RUN and TBC1 domain containing 2 1.662  -- 
NM_024614 hypothetical protein FLJ13197 1.622  -- 
NM_000399 
early growth response 2 (Krox-20 homolog, 
Drosophila) 1.601  -- 
NM_003407 
zinc finger protein 36, C3H type, homolog 
(mouse) 1.596  -- 
AL038125; Unannotated 1.552  -- 
NM_024636 tumor necrosis factor, alpha-induced protein 9 1.55 0.559 
NM_181644 hypothetical protein DKFZp761N1114 1.547  -- 
NM_152556 hypothetical protein FLJ31818 1.53  -- 
NM_173491 LSM11, U7 small nuclear RNA associated 0.666  -- 
BC035180; Unannotated 0.656  -- 
NM_032441 zinc finger, matrin type 1 0.638 1.819 
AK097587 
Homo sapiens chromosome 10 open reading 
frame 82 0.637 0.559 
BM676597 SET and MYND domain containing 4 0.614 -- 
THC2406165 Unannotated 0.596 0.641 
NM_194449 
pleckstrin homology domain containing, family 
E (with leucine rich repeats) member 1 0.587  -- 
THC2344910 Unannotated 0.583  -- 
THC2431122 
Voltage-dependent sodium channel alpha 
subunit protein (Fragment), partial (18%  -- 2.178 
AF213987; ALL1 fused gene from 5q31  -- 1.892 
NM_001010860 Chromosome 14 open reading frame 174  -- 1.891 
NM_033516 protein kinase NYD-SP25  -- 1.797 
THC2278570 Unannotated  -- 1.78 
NM_021807 SEC8-like 1 (S. cerevisiae)  -- 1.707 
NM_024873 TNFAIP3 interacting protein 3  -- 1.69 
AK022016 Myosin 1E  -- 1.67 
THC2278570 Unannotated  -- 1.574 
NM_020971 spectrin, beta, non-erythrocytic 4  -- 1.552 
NM_020211 RGM domain family, member A  -- 0.665 
NM_030649 centaurin, beta 5  -- 0.646 
BC043255 Unannotated  -- 0.592 
NM_005674 zinc finger protein 239  -- 0.58 
NM_020203 
matrix, extracellular phosphoglycoprotein with 
ASARM motif (bone)  -- 0.545 
NM_019023 protein arginine N-methyltransferase 7  -- 0.526 
NM_004352 cerebellin 1 precursor  -- 0.507 
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Further studies were performed to determine whether reticulocyte contamination was 
responsible for the detected expression of HBB.  Anti-glycophorin A magnetic beads 
were used to remove contaminating RBCs and reticulocytes from neutrophils prior to 
application to stimulated ECs.  Studies were also performed in which RBCs and 
reticulocytes were removed from trypsinized ECs just prior to RNA isolation in order to 
investigate whether RBC interaction with ECs could lead to HBB expression in ECs.  In 
both cases, qRT-PCR revealed that over 99% of the HBB expression found in ECs 
following neutrophil transmigration was actually derived from contaminating 
reticulocytes rather than an actual up-regulation of HBB expression within the ECs. 
 
Discussion 
We found 3617 differentially expressed genes following 5 or 7 hours of IL1β stimulation 
that had not been previously reported in microarray data of IL1β stimulated HUVEC.  
Grouping all of the differentially expressed genes into categories using DAVID revealed 
prominent biological responses which occur as a result of IL1β stimulation (Table 2).  As 
differential expression of 3617 genes constitutes over 5% of the human genome, the 
global impact that IL1β stimulation has on HUVEC mRNA expression is revealed.   
 
Previous microarray studies of IL1β treatment of ECs used either smaller array sets or 
more stringent cutoffs for identifying differentially expressed genes 3-5.  In this study we 
chose to use a 1.5 fold change in gene expression as well as a 95 % confidence interval to 
identify differentially expressed genes from within the Agilent Whole Human Genome 
array set.  Based on these criteria, our study identified numerous differentially expressed 
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genes which had not been previously reported and confirmed the data of previous 
microarray studies on IL1β stimulated ECs.     
 
Table 3 shows highly up-regulated genes that have previously been reported as up-
regulated by IL1β 3-5.  IL8, which was the most up-regulated gene at ~100 fold, is a 
chemokine known to cause neutrophil chemotaxis, degranulation, and adhesion molecule 
expression 45.  E-selectin and VCAM1 are also highly up-regulated at ~60 fold and ~10 
fold, respectively.  These molecules are surface adhesion molecules, with E-selectin 
acting as an adhesion molecule during the initial rolling stage of leukocyte transmigration 
and VCAM1 binding during the adherent phase of leukocyte transmigration 46.   COX2 
was up-regulated over 30 fold in ECs following IL1β stimulation.  COX2 is an enzyme 
which produces prostaglandin H2, a powerful mediator of inflammation 47.  Ubiquitin D, 
also known as FAT10 or diubiquitin, is up-regulated ~10 fold by IL1β stimulation.  
Ubiquitin D marks proteins for proteasomal degradation and may play a role in 
modulating apoptosis 48.  Fractalkine is up-regulated 10-20 fold by IL1β stimulation of 
endothelial cells.  A recent study suggests that fractalkine expression on the EC surface 
stimulates P-selectin expression on adherent platelets which then leads to firm adhesion 
of leukocytes under arterial shear stresses 49.   
 
We used DAVID to identify overrepresented functional groups which were differentially 
regulated by IL1β treatment (Table 2).  IL1β is well known to activate the NF-κB 
pathway.  The NF-κB pathway induces transcription of a number of anti-apoptotic genes 
including BFL1 and TRAF1 50.  Other studies have shown that IL1β induces apoptosis 
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when protein synthesis is impaired 51.  In our study both apoptotic (e.g. up-regulation of 
CASP3, up-regulation of TNF) and anti-apoptotic (e.g. up-regulation of BFL1 and 
TRAF1) gene regulation was observed.  Our study showed similar regulation of genes 
involved in control of the cell cycle.  Cozzolino et al. reported halting of endothelial cells 
in the G1 phase following IL1β treatment 52; however, a recent proteomics study reported 
that the cytokine TNFα, but not IL1β, halts cell cycle progression 53.   
 
IL1β signaling through the IL1β receptor is well known to activate the transcription 
factor NF-κB 54.  In our study a number of genes related to NF-κB activation and 
downstream signaling were differentially regulated.  IL1β signaling is also well known to 
induce chemotaxis through the expression of chemokines.  In our study we found up-
regulation of CCLs 1, 2, 7, 8, and 20, CXCLs 1, 2, 3, 5, 6, 10, and CX3CL1 following 
IL1β treatment (Figure 4).   
 
Through DAVID we also identified genes related to proteoglycan metabolism as being an 
overrepresented functional group.  Our results showed down-regulation of a number of 
sulfotransferases and other enzymes involved in proteoglycan synthesis.  This is 
consistent with reduced proteoglycan synthesis in porcine endothelial cells following 
IL1β treatment as shown by Skop et al. 55.  Genes related to chromosome organization 
are also overrepresented among our list of genes differentially expressed following IL1β 
treatment.  Studies have shown that IL1β affects histone acetylation in regulating 
downstream gene expression 56.  Our study showed up-regulation of a number of histone 
 
 33
genes as well as chromosome binding genes which may play a role in chromosome 
organization.   
 
The relationship between IL1β stimulation and angiogenesis has been studied both in 
vitro and in vivo with most studies indicating that IL1β is pro-angiogenic 57.  In our study 
a number of genes related to angiogenesis were differentially expressed, including VEGF 
up-regulation and neuropilin down-regulation.  One of the most well characterized 
examples of IL1β involvement in hemopoiesis is IL1β -mediated production of GCSF, 
which stimulates progenitor cell differentiation to granulocytes 58.  In our study GCSF 
was up-regulated ~30 fold along with other differentially regulated molecules related to 
hemopoiesis. 
 
Our study has shown IL1β induced up-regulation of claudin-1 mRNA expression along 
with down-regulation of claudin-5 and occludin mRNA expression.  qRT-PCR was used 
to confirm differential expression of these 3 genes which are known to localize to cell-
cell junctions.  These genes were chosen for further study based on the importance of 
cell-cell junctions in endothelial barrier function and neutrophil transmigration.  IL1β 
increases endothelial cell layer permeability 59 and decreases transendothelial resistance 
60. Cell-cell junction associated proteins, such as occludin and members of the claudin 
family, have been shown to be involved in regulation of endothelial barrier properties 
(Reviewed by Bazzoni 61).  Other studies have shown similar results in retinal pigment 
epithelial cells and astrocytes, indicating that claudin-1 is up-regulated by IL1β while 
occludin is down-regulated 62,63.  These findings suggest that altered claudin and occludin 
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expression may play a role in IL1β induced changes in endothelial permeability and 
transendothelial resistance in HUVEC.   
 
Claudin-5 has been shown to be important in establishing barrier function within the 
blood brain barrier 64.  However, Fontijn et al. recently published data suggesting that the 
role of claudin-5 may be limited in establishing barrier function in endothelial cells which 
are not associated with the blood brain barrier 65.  This group found that silencing of 
claudin-5 expression in HUVEC did not alter endothelial permeability.    
 
Up-regulation of PBEF following HUVEC treatment with IL1β was confirmed by qRT-
PCR and western blotting.  PBEF, also known as visfatin, is a protein which is believed 
to exhibit both extracellular cytokine activity as well as intracellular enzymatic activity 66.  
PBEF mRNA expression is up-regulated in amniotic epithelial cells by mechanical 
stretch 67 as well as by IL1β, TNFα, and IL6 68.  PBEF siRNA has been shown to 
attenuate PBEF protein expression in thrombin stimulated human pulmonary artery 
endothelial cell monolayers 69.  Thrombin treated endothelial cells normally exhibit 
decreased barrier function in the form of decreased transendothelial resistance; however, 
pretreatment of ECs with PBEF siRNA prior to thrombin stimulation resulted in a smaller 
drop in transendothelial resistance as compared to ECs treated with scrambled siRNA 
followed by thrombin 69.  These results indicate that PBEF is up-regulated by 
inflammatory mechanisms and contributes to changes in EC function as a result of these 




Differential regulation of claudin-1, claudin-5, occludin, and PBEF is transient, with 
mRNA expression levels returning to those of control HUVEC following 24 hours of 
IL1β stimulation (Figures 5 and 6).  This finding is indicative of the adaptive response of 
HUVEC to IL1β in order to prevent persistent activation of the endothelium which could 
lead to numerous vascular disorders.  Persistent endothelial activation in long term 
pathological conditions is likely sustained by participation of a combination of 
stimulating cytokines released from leukocytes and platelets 70. 
 
Our study also examined the impact of magnetic cell separation on EC gene expression.  
Endothelial cells were negatively selected by removing neutrophils from the EC 
population using CD45 Microbeads (Miltenyi).   This negative selection process had very 
little impact on EC gene expression as compared to ECs which were not exposed to 
CD45 Microbeads.  These results provide further validation for the use of magnetic cell 
separation in sample preparation for gene expression studies. 
 
A number of studies have investigated the impact of leukocyte-EC interactions on 
endothelial cell signaling.  Etienne et al. showed increased phosphorylation of focal 
adhesion molecules following ICAM1 cross-linking 7.  In a similar study, van Wetering 
et al. showed RAC activation and increased phosphorylation of p38 MAPK following 
cross-linking of VCAM1 71.  Huang et al. found a 5 to 8 fold increase in the cytosolic 
calcium levels of HUVEC following neutrophil transmigration 8.  Marcus et al. showed 
that direct contact of neutrophils with ECs resulted in a decrease in transendothelial 
resistance while Cepinskas et al. showed that neutrophil transmigration results in a dose 
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dependent reduction of NF-κB levels 10,11. Based on these and similar studies, van Buul 
and Hordijk hypothesized that leukocyte binding of ICAM1 and VCAM1 could lead to 
endothelial cell signaling which results in loss of endothelial cell-cell adhesion 72.    
 
Microarray analysis revealed that relatively few differentially expressed genes could be 
identified following neutrophil transmigration.  These results were unexpected based on 
previous studies of neutrophil adhesion and transmigration which identified a number of 
signaling events within ECs, which would be expected to be linked to transcriptional 
changes.  We suggest that transcriptional changes resulting from neutrophil adhesion and 
transmigration are overshadowed in comparison to the large background of differential 
expression induced by IL1β.   
 
Our study has revealed a number of global transcriptional changes occurring within ECs 
in response to IL1β stimulation.  These differentially expressed genes represent important 
pathways within the cell including apoptosis, cell cycle regulation, NF-κB cascade, 
chemotaxis and the immune response.  Differential expression of claudin-1, claudin-5, 
occludin, and PBEF were confirmed following IL1β stimulation of ECs.  Claudin-5, 
claudin-1, and occludin are all found at endothelial cell-cell junctions and differential 
expression may play a role in altered endothelial permeability following IL1β stimulation.  
In addition the cytokine PBEF has been shown to affect endothelial permeability in 
thrombin stimulated HUVEC and may have a similar role in IL1β stimulated HUVEC.  
Studies on post-transcriptional changes, particularly the relationship among the tight 
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junction proteins, will be required to elucidate the functional impact of IL1β on ECs, and 
how cytokine responses of ECs lead to inflammation and presage cardiovascular disease. 
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CHAPTER 3:  TRANSMIGRATION ACROSS ACTIVATED ENDOTHELIUM 




Monocytes are phagocytic cells that play a key role in inflammation.  In response to 
infection, these cells migrate out of the blood stream and differentiate into either 
macrophages which activate the innate immune response or dendritic cells which activate 
the adaptive immune response.  Monocyte migration to a site of inflammation begins 
with rolling along activated endothelial cells (ECs), followed by firm adhesion to ECs, 
and finally diapedesis across the endothelium towards a chemoattractant.  One 
mechanism of EC activation is exposure to interleukin 1 beta (IL1β) which induces 
expression of E-selectin, intercellular adhesion molecule 1 (ICAM1), and vascular cell 
adhesion molecule 1 (VCAM1) on the endothelial surface 73.  Monocytes interact with 
these adhesion molecules, leading to rolling and firm adhesion to the endothelium 74-76.  
Interaction with adhesion molecules has been shown to induce outside-in signaling events 
within leukocytes which may lead to downstream changes in leukocyte transcription 
72,77,78.   
 
Activation of ECs through exposure to IL1β also induces release of cytokines and other 
secreted factors (e.g. macrophage inflammatory proteins, monocyte chemotactic proteins, 
and fractalkine) 73, which have been shown to stimulate monocyte activation and 
recruitment 79-81.  During diapedesis, monocytes undergo changes in shape and interact 
with molecules found in EC junctions.  Monocytes bind to junctional adhesion molecules 
and platelet/endothelial cell adhesion molecule (PECAM1) on the EC surface during 
diapedesis via lymphocyte function-associated antigen 1 (LFA1) and PECAM1, 
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respectively 76.  This binding may induce inside-out signaling within the monocyte 82.  
All of the steps in transmigration may contribute to downstream changes in monocytes 
which lead to either inflammatory resolution or pathogenesis.   
 
To understand the effects of transmigration on monocyte gene expression, we used 
microarrays to identify transcriptional changes in freshly isolated human monocytes that 
had transmigrated across a layer of IL1β-stimulated ECs.  Control conditions were used 
to further characterize which steps of transmigration are responsible for inducing these 
changes.  Microarray analysis revealed that monocyte transmigration promotes further 
leukocyte recruitment, induces expression of genes involved in the inhibition of apoptosis, 
and reduces gene expression of anti-microbial proteins.  These findings were confirmed 
with qRT-PCR, immunoblots, and apoptosis assays. 
 
Materials and Methods 
Cell culture and monocyte isolation 
Pooled human umbilical vein endothelial cells (HUVEC) were purchased from Lonza 
and cultured in HUVEC media, composed of M199 media (Mediatech) containing 20% 
fetal bovine serum (Hyclone), 50 U/mL penicillin (Gibco), 50 μg/ml streptomycin 
(Gibco), 2mM L-glutamine (Mediatech), 2.5 U/ml heparin (American Pharmaceutical 
Partners), and 50 μg/ml endothelial mitogen (Biomedical Technologies).  Passage 3-4 
HUVEC were seeded at 50,000 cells/cm2 onto porcine gelatin coated (0.2% wt/vol in 
phosphate buffered saline (PBS)) polycarbonate cell culture inserts (diameter = 75mm) 
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containing 3 μm pores (Corning) and cultured until confluent at 37 oC in the presence of 
humidified 5% CO2.   
 
Monocytes were isolated from whole blood obtained from healthy adult donors according 
to an institutional review board approved protocol in which all participants gave written 
informed consent.  Blood was drawn into citrate buffer anticoagulant and combined with 
an equal volume of 6% Dextran 70  solution (B. Braun).  This mixture was layered over 
lymphocyte separation media (1.078 g/mL, Cellgro) and centrifuged for 30 minutes at 
400g.  Following centrifugation, peripheral blood mononuclear cells (PBMCs) were 
obtained from the interface which formed between the lymphocyte separation media and 
saline solution.  To remove platelets, PBMCs were rinsed twice by centrifugation in PBS 
at 250g for 10 minutes.  Monocytes were negatively selected from the PBMCs using a 
MACS Monocyte Isolation Kit II (Miltenyi) with slight modifications to the 
manufacturer's protocol.  For 30 mL of blood, PBMCs were pelleted and resuspended in 
88 uL of MACS buffer (0.5% human serum albumin and 2 mM EDTA in PBS).  Thirty 
μL each of FcR solution and antibody cocktail as provided in the monocyte isolation kit 
were added to the PBMCs.  In addition 1 μL each of biotinylated CD2 (BD Biosciences) 
and CD42b (Genetex) antibodies were added to the PBMCs and the mixture was 
incubated at 4 oC for 10 minutes.  Following this incubation period, 65 uL magnetic 
beads, as provided by Miltenyi, and 85 μl MACS buffer were added to the PBMCs with 
an additional 15 minute incubation period at 4 oC.  PBMCs were then rinsed and 
resuspended in MACS buffer.  Other cell types were removed from the monocytes by 
passing the cell mixture over a LS column placed in a MACS Magnetic Separator 
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(Miltenyi).  Monocytes were collected in the flow-through from the magnetic column.  
Purified monocytes were maintained in minimal essential media (MEM) with 0.5% 
human serum albumin at 37 oC until application to HUVEC and used within two hours 
following isolation.  In this procedure CD2 and CD42b antibodies were necessary 
additions to the antibody cocktail in order to remove platelets and a small number of 
lymphocytes which remained when the unmodified manufacturer's protocol was used.  
Monocyte populations were assessed by Wright-Geimsa staining of cytospin preparations 
and found to be greater than 95% pure (Shandon Cytospin).   
 
Experimental protocol 
Twenty-four hours after the endothelial cells reached confluence, the media was replaced 
with HUVEC media containing 100 pg/ml IL1β.  Seven hours later, stimulated ECs were 
washed thoroughly 3 times with MEM.  Then the insert with the ECs was transferred to a 
new agarose-coated tissue culture dish.  Ten million freshly isolated monocytes in MEM 
with 0.5% HSA were placed above the stimulated ECs for 1.5 h.  Following a 1.5 h 
incubation, monocytes that successfully transmigrated were collected (Figure 8C “TM”).  
As a control, monocytes that were applied above ECs but failed to transmigrate were 
collected (Figure 8C “UMA”).  As another control, monocytes that were placed beneath 
stimulated ECs for 1.5 h, but never allowed to physically contact the ECs, were collected 
(Figure 8B “UMB”).  As a final control, untreated monocytes were collected from an 
agarose-coated tissue culture dish following a 1.5 h incubation period (Figure 8A 




Figure 8:  Four monocyte populations collected for microarray and downstream analysis.   
A) Untreated monocytes (UNT) were collected following 1.5 hour incubation on agarose coated tissue 
culture dishes in MEM with 0.5% HSA.  B) Monocytes (UMB) were collected following 1.5 hour 
incubation on agarose coated tissue culture dishes beneath IL1β stimulated HUVEC grown on 
polycarbonate cell culture inserts containing 3 μm pores.  These monocytes have been exposed to EC 
secretions that have diffused into the lower chamber, but have not directly contacted ECs. C) Monocytes 
that failed to transmigrate (UMA) during a 1.5 hour incubation with IL1β stimulated HUVEC grown on 
cell culture inserts were collected.  These monocytes have contacted stimulated ECs and been exposed to 
EC secretions.  Monocytes that transmigrated (TM) during 1.5 hour incubation with IL1β stimulated 
HUVEC grown on cell culture inserts were collected.  These monocytes have undergone the process of 




Prior to RNA isolation, monocyte populations were further purified using CD105 
Microbeads (Miltenyi) according to the manufacturer's protocol to remove contaminating 
ECs which made up 3-5% of the cell population.  Effectiveness of this purification step 
was measured by performing the transmigration protocol using freshly isolated 
monocytes labeled with Cell Tracker Orange (Invitrogen) and ECs labeled with Cell 
Tracker Green (Invitrogen).  Flow cytometry was used to assess purity of the monocyte 
population and indicated less than 1% contamination following the EC removal step.   
 
Following this purification step, cells were counted with a Beckman Coulter Z2 Particle 
Count and Size Analyzer to determine percent transmigration.  RNA and protein were 
isolated with TRI-zol (Invitrogen) according to the manufacturer's instructions, followed 
by DNA removal using an RNA Cleanup Kit (Qiagen).  RNA quantity and quality were 
assessed by loading 1 μl of sample RNA onto a RNA 6000 Nano chip (Agilent) and 
analyzing with an Agilent 2100 Bioanalyzer to determine the amount and integrity of 
RNA recovered.  Monocyte samples having an RNA Integrity Number of 7.5 or greater 
and at least 250 ng of total RNA were used for microarray experiments.     
 
Microarrays 
Microarray hybridization and imaging were performed at the Morehouse School of 
Medicine Functional Genomics Core Facility.  Briefly, RNA and Universal Human 
Reference RNA (Stratagene) were linearly amplified to cRNA using a Low RNA Input 
Fluorescent Linear Amplification Kit (Agilent).  Cy5-labeled cRNA for each sample was 
competitively hybridized with Cy3-labeled reference cRNA to a 44k Whole Human 
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Genome Microarray (Agilent) according to the manufacturer’s instructions.  Slides were 
dried under nitrogen and scanned on an Agilent DNA Microarray Scanner.  Microarray 
images were analyzed with Agilent Feature Extraction Software.  GeneSpring 7.3 
software was used to analyze the microarray data with one way ANOVA assuming equal 
variances followed by a post hoc Student-Neuman-Keuls test.  Differentially expressed 
genes were identified as those which had changes of at least 2 fold and adjusted p-values 
of less than 0.05.  Microarray data has been deposited in NCBI’s Gene Expression 
Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/) and is accessible through GEO 
Series accession number GSE14027. 
 
Functional Grouping of Differentially Expressed Genes 
Lists of differentially expressed genes were uploaded to the Database for Annotation, 
Visualization and Integrated Discovery (DAVID) and subjected to Functional Annotation 
Clustering at medium class stringency in order to identify enriched biological themes 44.  
Gene Ontology (GO) Biological Process annotations were used to perform this functional 
clustering.  Lists of up-regulated and down-regulated genes were uploaded separately to 
DAVID in order to identify enriched pathways and map differentially expressed genes to 
these pathways. 
 
Quantitative Real Time PCR 
Total RNA from each sample was reverse transcribed into cDNA using SuperScript II 
(Invitrogen).  cDNA was purified with Micro Bio-Spin P-30 Chromatography Columns 
(BioRad), and diluted in RT-PCR Grade Water (Ambion).  Pre-designed PCR primers 
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and Quantitect SYBR Green PCR Master Mix were purchased from Qiagen.  Primers 
were added to the master mix at a ratio of 1:5.  Each reaction was performed with 4 μl of 
diluted cDNA and 6 μl of primers in the master mix.  The qRT-PCR reactions were 
performed on a LightCycler 2.0 (Roche Applied Science) with a 15 minute activation 
step at 95 oC; 50 cycles at 94 oC for 15 seconds, 55 oC for 20 seconds, 72 oC for 20 
seconds; and a ramped melting cycle.  Fold changes were determined using the ΔΔCt 
method.  Statistical differences in fold changes were assessed with one way ANOVA 
followed by a post-hoc Tukey multiple comparison test.  qRT-PCR was used to verify 
gene expression from RNA isolated from three independent monocyte transmigration 
experiments.   
 
Immunoblotting 
For detection of α-defensin or β-actin protein expression, 15 μg of protein or 5 μg of 
protein, respectively, was blotted onto a nitrocellulose membrane (Pall Life Science).  
After blocking with 5% nonfat dry milk, membranes were probed with mouse 
monoclonal α-defensin antibodies (GeneTex), or mouse monoclonal β-actin antibodies 
(Sigma).  Bound primary antibodies were labeled with horseradish peroxidase conjugated 
secondary antibodies and detected with enhanced chemiluminescence (ECL Plus, 
Amersham Biosciences).  Net intensities of α-defensin expression were quantified by 
densitometry with the Kodak EDAS 1D Imaging System (Kodak) and normalized to β-
actin net intensities.  Immunoblots were performed using protein isolated from 4 separate 
time course experiments and statistical significance was assessed using one way ANOVA 
followed by a post hoc Tamhane test for unequal variances.  The post hoc Tamhane test 
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was chosen over the Tukey multiple comparison test because Bartlett's test for equal 
variances showed unequal variances, indicating that the Tukey test is inappropriate 83,84. 
 
Apoptosis Assays 
Cells were collected from each of the four experimental conditions and washed in cold 
PBS.  Freshly isolated monocytes were treated for 3 hours with 2 μM staurosporine or 2 
mM hydrogen peroxide as positive controls for apoptosis and necrosis, respectively.  
Cells were then stained with R-phycoerythrin (R-PE) conjugated Annexin V and SYTOX 
Green using the Vybrant Apoptosis Kit no. 8 (Molecular Probes, Eugene, OR) according 
to the manufacturer's instructions.  Samples were analyzed by flow cytometry, measuring 
the fluorescence emission at 530 nm and 575 nm.  The percentage of apoptotic cells was 
calculated using FlowJo software (Tree Star, Inc.). 
 
Results 
Monocyte Transmigration and Recovery 
In control conditions, approximately 70% of the monocytes placed on agarose-coated 
dishes were collected after a 1.5 h incubation period.  When monocytes were placed 
above stimulated ECs for 1.5 h, 23 +/- 7% of the applied monocytes were collected from 
the dish beneath the ECs.  An additional 25 +/- 13% of the applied monocytes failed to 
transmigrate and were collected from above the stimulated ECs.  The remaining 
monocytes which were not recovered following incubation with ECs may have become 
adherent to the ECs, failed to completely move across the polycarbonate cell culture 
inserts, or been lost in the monocyte purification steps.   
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Fold Change  
(TM vs UNT) 
CCL2 Monocyte Chemotactic Protein 1 14.8 
CCL7 Monocyte Chemotactic Protein 3 14.4 
TNIP3 TNFAIP3-Interacting Protein 13.6 
EMP1 Epithelial Membrane Protein 1 13.6 
BATF Activating Transcription Factor B 9.1 
DMD Dystrophin 9.1 
IL2RA IL2 Receptor A 8.7 
CTSL1 Cathepsin L 8.3 
THEX1 Three Prime Histone Exonuclease 7.9 
LMNB1 Lamin B 1 7.7 
CST6 Cystatin 6    0.21 
NTF3 Neurotrophin 3   0.20 
CNTROB Centrobin  0.19 
NKX2-3 NK2 Transcription Factor related, locus 3  0.19 
MUC8 Mucin 8  0.18 
PLA2G4A Phospholipase A2 Group IVA  0.17 
VIL1 Villin  0.17 
FANCI Mitochondrial Polymerase Gamma  0.17 
CAMP Cathelicidin Antimicrobial Peptide  0.11 




Global Effects of the Transmigration Process 
Comparison of gene expression in transmigrated monocytes to gene expression in 
untreated monocytes revealed up-regulation of 489 genes and down-regulation of 203 
genes following transmigration.  The top 10 up-regulated and down-regulated genes are 
shown in Table 6.  Interestingly the most highly up-regulated genes, monocyte 
chemotactic proteins 1 and 3, are both chemokines known to strongly attract monocytes.  
Thus, transmigrating monocytes may be involved in recruiting other monocytes through 
the production of chemokines.  The most highly down-regulated genes, α-defensin 3 and 
cathelicidin antimicrobial peptide, are both peptides which have known antimicrobial 
activity.  A list of all of the differentially expressed genes in transmigrated monocytes 
compared to untreated monocytes can be found in Supplemental Table 4. 
 
Functional annotation clustering was performed using the Database for Annotation, 
Visualization, and Integrated Discovery (DAVID) to identify enriched biological themes 
or functional groups among these 692 up- and down-regulated genes.  Genes identified as 
being down-regulated are involved in cell cycle arrest, DNA metabolism, and actin 
filament depolymerization.  Up-regulated genes are involved in the immune response, the 
protein kinase cascade, and inhibition of apoptosis.  Genes associated with these 
functional groups are shown in Figure 9 with red indicating up-regulation, yellow 
indicating no significant change in expression, and blue indicating down-regulation.  It 




















































































































































































































































































treatment conditions as compared to untreated monocytes (e.g. monocyte chemotactic 
protein 1 (CCL2) and suppressor of cytokine signaling 3 (SOCS3)) while other genes are 
differentially expressed in only one or two of the monocyte treatment conditions as 
compared to untreated monocytes.  This result indicates that some differentially 
expressed genes are responding to a stimulus that is found in all of the monocyte 
treatment conditions (i.e. cytokine secretions from IL1β stimulated HUVEC) while other 
differentially expressed genes are responding to stimuli that are only found in some of the 
monocyte treatment conditions (i.e. EC contact or diapedesis).  A more complete 
examination of the individual effects of these stimuli follows. 
 
qRT-PCR Confirmation 
Five up-regulated genes and 4 down-regulated genes were selected for qRT-PCR 
confirmation of the microarray results.  The 5 up-regulated genes were chosen for 
confirmation because of their inclusion in the negative regulation of apoptosis functional 
group (Figure 9).  The 4 down-regulated genes were chosen for confirmation because of 
their inclusion in the defense response functional group (See “Effects of Diapedesis” 
below). Patterns of differential expression as observed by microarray analysis closely 
resembled patterns of differential expression detected by qRT-PCR.  A comparison of 




Table 7:  Comparison of microarray and qRT-PCR fold changes 







25.0 +/- 12.8 
5.4 
14.7 +/- 9.4 
8.3 




24.0 +/- 7.3 
8.6 
11.4 +/- 3.0 
11.4 




4.4 +/- 0.3 
6.7 
9.7 +/- 4.6 
9.0 




3.1 +/- 0.2 
1.1 
3.4 +/- 0.9 
1.5 




3.3 +/- 0.01 
2.5 
1.6 +/- 0.3 
1.5 




0.26 +/- 0.21 
2.7 
2.4 +/- 0.6 
1.2 




0.045 +/- 0.017 
2.6 
2.7 +/- 0.7 
1.2 




0.11 +/- 0.03 
3.0 
2.5 +/- 0.5 
1.2 






3.5 +/- 1.3 
0.9 
1.2 +/- 0.2 
Average fold changes for microarray data were obtained from Genespring 7.0 following normalization 
procedures.  For qRT-PCR data, fold changes represent the average +/- SEM for 3 experiments. Red genes 
indicate up-regulation of at least 2 fold and green genes indicate down regulation of at least 2 fold. 
 
Transmigration Inhibits Apoptosis 
Ingenuity Pathways Analysis was used to map up-regulated genes belonging to the gene 
ontology term “Negative Regulation of Apoptosis” to the apoptosis pathway.  A portion 
of this pathway is shown in Figure 10, for the complete pathway, please see 




Figure 10:  Transmigration Causes Differential Expression of Genes in the Apoptosis Pathway.   
Genes belonging to the “Negative Regulation of Apoptosis” functional group were mapped to the apoptosis 
pathway.  Apoptosis is shown at the bottom of the pathway.  Caspase 3 and caspase 9 are key enzymes in 
promoting apoptosis by activation through enzymatic cleavage of a number of proteins which control 
apoptotic functions such as chromatin condensation, DNA fragmentation, and membrane blebbing.  Both of 
these caspase genes are inhibited by neuronal apoptosis inhibitory protein (NAIP) which is up-regulated in 
transmigrated monocytes compared to untreated monocytes as indicated by the gray coloring.  Various 
intracellular and extracellular signaling pathways are involved in expression and inhibition of caspase 3, 




Apoptosis is shown at the bottom of Figure 10 and is preceded by chromatin 
condensation, DNA fragmentation, cell shrinkage, and membrane blebbing.  These 
cellular activities are mediated by various proteins including ACIN1 (apoptotic chromatin 
condensation inducer 1), CAD (caspase activated DNAse), and GAS2 (growth arrest 
specific 2).  The activity of each of these proteins is regulated by caspase 3 and caspase 9.  
Further examination of Figure 3 reveals that NAIP (neuronal apoptosis inhibitory protein) 
inhibits caspase 3 and caspase 9 activity.  The gray coloring of NAIP indicates that in our 
microarray data this gene was up-regulated in transmigrated monocytes compared to 
untreated monocytes.  qRT-PCR confirmed up-regulation of NAIP in transmigrated 
monocytes  as compared to untreated monocytes (Table 7).  Significant increases in 
NAIP expression were not seen in monocytes incubated below stimulated ECs or in 
monocytes which failed to transmigrate.   
 
Functional Assay of Apoptosis 
Apoptosis assays were performed on monocyte populations using AnnexinV binding to 
phosphatidyl serine on the outside of the cell membrane as an indicator of monocyte 
apoptosis.  SYTOX green labeling of DNA in monocytes having a compromised cell 
membrane was used as an indicator of late stage apoptosis or necrosis.  Representative 
flow cytometry dot plots are shown in Figure 11A-D.  Approximately 20% of untreated 
monocytes were found in the apoptotic quadrant, Q4, with positive staining for Annexin 
V binding and without uptake of SYTOX green (Figure 11A).  Monocytes which failed 
to transmigrate (Figure 11C) and monocytes incubated beneath stimulated ECs (Figure 




Figure 11:  Apoptosis is reduced in monocytes following transmigration.    
(A-D) Representative dot plots of R-PE labeled-annexinV and SYTOX green labeled monocytes from each 
of the four monocyte populations.  Q1 – No cells.  Q2 – Necrotic or late apoptotic cells.  Q3 - Live 
monocytes.  Q4 - Apoptotic monocytes.  (E) Quantitation of monocyte apoptosis in four experiments, bars 




transmigration only about 5% of the monocytes were apoptotic (Figure 11D), indicating 
that transmigration reduces monocyte apoptosis.  Quantification of apoptosis in each of 
the four monocyte treatment conditions from four experiments is shown in Figure 11E, 
indicating that transmigrated monocytes have a significant reduction in apoptosis as 
compared to untreated monocytes.   
 
Steps in Transmigration Process 
Comparison of gene expression in transmigrated monocytes and untreated monocytes 
indicates that the monocyte transcriptome is altered by the process of transmigration; 
however, it does not allow for determination of which specific steps in the transmigration 
process are responsible for these changes.  Control conditions were used to identify 
which steps of transmigration (i.e. exposure to endothelial secretions, monocyte-
endothelial contact, or diapedesis) are responsible for altered monocyte gene expression.   
 
Effects of IL1β-Induced Endothelial Secretions 
 
We expected that a number of gene changes seen between transmigrated monocytes and 
untreated monocytes were induced by exposure to EC secretions resulting from IL1β 
treatment of the ECs.  In our studies transmigrated monocytes (Figure 8 “TM”), 
monocytes which failed to transmigrate (Figure 8 “UMA”), and monocytes incubated 
beneath stimulated ECs (Figure 8 “UMB”) were all exposed to EC secretions.  We 
identified 119 genes which were differentially expressed in all of the monocyte 
conditions that were exposed to EC secretions as compared to untreated monocytes 
(Supplemental Table 5).  Fold changes were similar among all of the conditions for 99%  
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Table 8:  Functional groups associated with up-regulation by EC secretions. 






     CCL2, monocyte chemotactic protein 1 14.8 8.6 11.4 
     CCL7, monocyte chemotactic protein 3 14.4 5.4 8.3 
     IL1RN, interleukin-1 receptor antagonist 6.9 4.8 3.5 
     IL19, interleukin-19 3.6 2.9 2.2 
     CXCR5, chemokine (c-x-c motif) receptor 5 2.5 2.3 3.5 
     TLR4, toll-like receptor 4 2.8 2.4 2.2 
CELLULAR COMPONENT ORGANIZATION    
     EMP1, epithelial membrane protein 1 13.6 6.4 5.5 
     CISH, cytokine inducible sh2-containing protein 7.1 9.0 8.4 
     SOCS3, suppressor of cytokine signaling 3 5.0 6.7 9.0 
     PDSS1, prenyl diphosphate synthase, subunit 1 6.2 3.5 2.8 
     KIF15, kinesin family member 15 2.5 3.2 4.6 
     FGD4, five, rhogef and ph domain containing 4 3.0 2.3 2.2 
SIGNAL TRANSDUCTION    
     RSPO3, r-spondin 3 homolog 3.9 4.3 2.5 
     CCL2, monocyte chemotactic protein 1 14.8 8.6 11.4 
     CCL7, monocyte chemotactic protein 3 14.4 5.4 8.3 
     TLR4, toll-like receptor 4 28 2.4 2.2 
     IL19, interleukin-19 3.6 2.9 2.2 
     CISH, cytokine inducible sh2-containing protein 7.1 9.0 8.4 
     FGD4, five, rhogef and ph domain containing 4 3.0 2.3 2.2 
     SOCS3, suppressor of cytokine signaling 3 5.0 6.7 9.0 
     MCTP2, multiple c2 domains, transmembrane 2 6.5 4.1 2.8 
     CXCR5, chemokine (c-x-c motif) receptor 5 2.5 2.3 3.5 
     CD69, cd69 antigen, early t-cell activation antigen 4.8 4.9 5.7 
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Table 9:  Functional groups associated with down-regulation by EC secretions. 
 FOLD CHANGE 
SIGNAL TRANSDUCTION  (TM/UNT)  (UMA/UNT) (UMB/UNT) 
 OPRK1, opiod receptor, kappa 1 0.28 0.35 0.21 
MAP4K5, mitogen-activated protein kinase kinase 
kinase kinase 5 
0.31 0.28 0.39 
guanine nucleotide-binding regulatory protein 0.30 0.30 0.40 
SFN, stratifin 0.35 0.36 0.39 
MED16, thyroid hormone receptor associated protein 5 0.40 0.32 0.43 
CENTG2, centaurin, gamma 2 0.46 0.34 0.35 
GRM5, glutamate receptor, metabotropic 5 0.37 0.46 0.37 
SPTB, spectrin, beta, erythrocytic 0.40 0.45 0.38 
DAB2IP, ngap-like protein 0.45 0.43 0.41 
NTRK2, neurotrophic tyrosine kinase, receptor, type 2 0.46 0.38 0.44 
FRAT2, frequently rearranged in advanced t-cell 
lymphomas 2 
0.43 0.45 0.48 
REGULATION OF TRANSCRIPTION    
ZNF367, zinc finger protein 367 0.24 0.29 0.35 
SETD2, huntingtin interacting protein b 0.30 0.24 0.35 
HOXC5, homeobox C5 0.31 0.35 0.32 
BHLHB5, basic helix-loop-helix domain containing, 
class b, 5 
0.32 0.37 0.33 
KIAA2018 0.47 0.36 0.29 
ZHX2, zinc fingers and homeoboxes 2 0.35 0.44 0.35 
MED16, thyroid hormone receptor associated protein 5 0.40 0.32 0.43 
PSPC1, paraspeckly component 1 0.40 0.31 0.50 
GLIS2, glis family zinc finger 2 0.44 0.42 0.41 




of the differentially expressed genes, indicating that exposure to EC secretions is 
responsible for differential expression of these genes.  Functional grouping using DAVID 
revealed that monocyte exposure to EC secretions causes up-regulation of genes involved 
in a number of biological processes including the immune response, cellular component 
organization, and signal transduction (Table 8).  Of particular interest is up-regulation of 
CCL2, CCL7, TLR4, IL19, and CXCR5 which are all cytokines or cytokine receptors 
that may be involved in further leukocyte recruitment and activation.  Exposure to EC 
secretions causes down-regulation of genes involved in intracellular signaling and 
transcription (Table 9). 
 
Effects of Monocyte-Endothelial Contact 
 
In our system both transmigrated monocytes (Figure 8 “TM”) and monocytes that failed 
to transmigrate (Figure 8 “UMA”) had contact with ECs, while monocytes placed 
beneath ECs (Figure 8 “UMB”) and untreated monocytes (Figure 8 “UNT”) had no EC 
contact.  Sixty-one genes were differentially expressed in monocytes that contacted ECs 
as compared to untreated monocytes (Supplemental Table 6).  Of these 61 genes, 34 are 
up-regulated and 27 are down-regulated.  Signal transduction and the immune response 
are some of the functional groups associated with genes up-regulated by monocyte 
endothelial cell-contact (Table 10).  Lipid metabolism is one of the functional groups 
associated with the down-regulated genes (Table 10).   
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Table 10:  Functional groups associated with genes differentially expressed by monocyte/EC contact. 
SIGNAL TRANSDUCTION FOLD CHANGE 
 (TM/UNT) (UMA/UNT) 
     GBG10, guanine nucleotide binding protein, gamma 10 5.6 3.0 
     MCTP2, multiple c2 domains, transmembrane 2 5.0 3.5 
     SUCNR1, succinate receptor 1 2.4 3.5 
     CCR1, chemokine (c-c motif) receptor 1 2.6 2.5 
     FPRL1, formyl peptide receptor-like 1 2.5 2.6 
     IL4R, interleukin 4 receptor 2.5 2.4 
     LITAF, lipopolysaccharide-induced tnf factor 2.7 2.0 
     PBEF, pre-b-cell colony enhancing factor 1 2.3 2.1 
IMMUNE RESPONSE   
     CCR1, chemokine (c-c motif) receptor 1 2.6 2.5 
     IL4R, interleukin 4 receptor 2.5 2.4 
     CLEC4D 2.4 2.0 
LIPID METABOLISM   
     PLA2G3, phospholipase a2, group iii 0.49 0.48 
     ST3GAL6, st3 beta-galactoside alpha-2,3-sialyltransferase 6 0.41 0.48 




Effects of Diapedesis 
 
In our system the only sample which went through diapedesis was transmigrated 
monocytes (Figure 8 “TM”).  Comparing transmigrated monocytes to all of the other 
conditions provides information about how the process of diapedesis alters monocyte 
transcription.  The Venn diagram in Figure 12 indicates that when transmigrated 
monocytes are compared to untreated monocytes, monocytes which failed to transmigrate, 
and monocytes incubated beneath stimulated endothelial cells there are 89 differentially 
expressed genes which are found to overlap in all of these lists.   Eighty of these genes 
were up-regulated while only nine were down-regulated (Supplemental Table 7).  
Functional grouping of these genes shows up-regulation of genes involved in cell 
differentiation and down-regulation of anti-microbial proteins (Table 11).   
 
Anti-Microbial Proteins 
Of the nine genes down-regulated by diapedesis, four of these are anti-microbial 
genes which are involved in non-oxidative killing of bacteria.  These genes include 
defensin alpha 3 (DEFA3), cathelicidin anti-microbial peptide (CAMP), lactoferrin (LTF), 
and cathepsin G (CTSG).  DEFA3, CAMP, and CTSG, are all peptides which have 
molecular weights of less than 30 kDa.  Lactoferrin is a larger iron binding protein with a 
molecular weight of 78 kDa.  qRT-PCR confirmed down-regulation of these genes as 
shown in Table 7.  Of these four anti-microbial genes, DEFA3 was the most down-





Figure 12:  Monocyte transmigration induces differential gene expression in comparison to untreated 
monocytes, monocytes that failed to transmigrate (Unmigrated Above), or monocytes incubated 
below stimulated ECs (Unmigrated Below). 
This Venn diagram of genes that are differentially expressed in transmigrated cells as compared to other 
treatment conditions shows the overlapping genes in each of the comparisons.  The 89 genes in the center 
of this Venn diagram are differentially expressed in transmigrated monocytes as compared to all of the 
other conditions.  The primary difference between transmigrated monocytes and the other three monocyte 
populations is that transmigrated monocytes have gone through the process of diapedesis.  This indicates 
that expression of these 89 genes is likely to be controlled by diapedesis. 
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Table 11:  Functional groups associated with genes differentially expressed by diapedesis. 
CELL DIFFERENTIATION FOLD CHANGE 
(TM/UNT) 
     DICER1, dcr-1 homolog 4.8 
     PMCH, pro-melanin-concentrating hormone 4.2 
     TNFRSF10D, tumor necrosis factor receptor superfamily, member 10d 3.8 
     ERBB4, v-erv-a erythroblastic leukemia viral oncogene homolog 4 3.8 
     GLDN, gliomedin 3.5 
     RTN4RL1, reticulon 4 receptor-like 1 3.4 
     HLA-DOA, major histocompatibility complex, class ii, do alpha 2.1 
SIGNAL TRANSDUCTION  
     FCGR2B, fc fragment of igg, low affinity iib, receptor 6.4 
     CD59, CD59 antigen, complement regulatory protein 4.8 
     PMCH, pro-melanin-concentrating hormone 4.2 
     RBJ, ras-associated protein rap1 3.9 
     TNFRSF10D, tumor necrosis factor receptor superfamily, member 10d 3.8 
     ERBB4, v-erv-a erythroblastic leukemia viral oncogene homolog 4 3.8 
     GPR112, g protein-coupled receptor 112 3.7 
     IL1RAP, interleukin-1 receptor accessory protein 3.6 
     RASA2, ras p21 protein activator 2 3.3 
     ADCY2, adenylate cyclase 2 2.1 
     TRIM38, tripartite motif-containing 38 3.2 
     MUSK, muscle, skeletal, receptor tyrosine kinase 2.7 
     FGD4, five, rhogef and ph domain containing 4 2.3 
DEFENSE RESPONSE  
     DEFA3, defensin, alpha 3 0.02 
     CAMP, cathelicidin antimicrobial peptide 0.11 
     LTF, lactotransferrin 0.21 
     CTSG, cathepsin G 0.38 
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α-defensin Protein Expression 
Because DEFA3 is the most down-regulated gene on the microarray, immunoblots were 
used to assess protein expression of DEFA3 and β-actin in each of the monocyte 
treatment conditions.  Representative immunoblots are shown in Figure 13A.  As with 
mRNA expression, protein expression of DEFA3 is decreased following transmigration 
and increased in monocytes which failed to transmigrate.  Protein expression from 5 
separate experiments was quantified and normalized to β-actin expression (Figure 13B).  
This reveals ~4.5 fold up-regulation of α-defensin expression in monocytes which failed 
to transmigrate as compared to untreated monocytes and ~2 fold down-regulation of α-
defensin expression in transmigrated monocytes.   
 
Figure 13:  α-defensin protein expression is decreased in transmigrated monocytes and increased in 
monocytes which failed to transmigrate (unmigrated above) as assessed by immunoblots.   
(A) Representative α-defensin and β-actin immunoblots.  (B) Quantitation of α-defensin protein expression 
normalized to β-actin expression followed by normalization to expression in untreated monocytes.  Bars 





We found differential expression of 692 genes following monocyte transmigration across 
activated ECs.  These differentially expressed genes indicate that transmigration induces 
transcription of cytokines, cytokine receptors, cell signaling genes, and genes which 
inhibit apoptosis (Figure 14A).  All of these findings indicate that transmigration induces 
a monocyte phenotype that is primed for response to extracellular cues which alter 
downstream functions of monocytes.  Our microarray data also indicated that a number of 
genes involved in the inhibition of apoptosis are up-regulated following transmigration.  
Inhibition of apoptosis in transmigrated monocytes is supported by previous studies in 
neutrophils which have found decreased apoptosis following transmigration 85,86.  
Regulation of apoptosis is important for monocytes to prevent premature cell death and to 
allow monocytes to differentiate into macrophages and dendritic cells.   Our microarray 
data is supported by functional assays revealing reduced apoptosis in transmigrated 
monocytes and by qRT-PCR confirming up-regulation of NAIP, an inhibitor of apoptosis, 
following transmigration.   We have interpreted this data to indicate that the process of 
transmigration leads to reduced apoptosis in monocytes.  Another possibility is that 
apoptotic monocytes do not transmigrate as efficiently as non-apoptotic monocytes.  
However, if this were true, we would expect to see an increase in apoptosis positive cells 
in the monocyte population which failed to transmigrate.  Examination of Figure 11E 
reveals that the monocytes which failed to transmigrate (unmigrated above) do not have 
increased levels of apoptosis, thus making it unlikely that early apoptotic monocytes have 





Figure 14:  Transmigration alters monocyte gene expression throughout the entire process.   
(A) Overall effects of monocyte transmigration.  (B) Transcriptional effects of monocyte exposure to 
secretions derived from IL1β stimulated ECs.  These genes showed differential expression in monocytes 
incubated below stimulated ECs, in monocytes which failed to transmigrate, and in transmigrated 
monocytes as compared to untreated monocytes.  (C) Transcriptional effects of monocyte-EC contact.  
These genes were differentially expressed in monocytes which failed to transmigrate and in transmigrated 
monocytes as compared to untreated monocytes.  (D) Transcriptional effects of diapedesis.  These genes 
were differentially expressed in transmigrated monocytes as compared to untreated monocytes, monocytes 
which failed to transmigrated, and monocytes incubated below stimulated ECs. Only a portion of the 
differentially expressed genes for each of the steps of transmigration are shown in this diagram.  Genes 
were chosen for display based on their inclusion in over-represented functional groups.  Full lists of 
differentially expressed genes for each step of transmigration can be found in the supplemental tables.  Fold 
changes listed represent the average fold change for each of the monocyte populations considered as 




We have also shown that monocyte transcription is affected by each of the steps of 
transmigration.  Monocyte exposure to endothelial secretions leads to increased 
expression of genes involved in the immune response (Figure 14B).  The two most highly 
up-regulated genes in this study, CCL2 and CCL7, are both chemokines which may 
promote further recruitment of monocytes.  Previous studies have shown that monocyte 
coculture with naive ECs causes increased expression of CCL2 87,88.  Takahashi et al. 
showed that monocytes which failed to adhere to naïve ECs did not show increases in 
CCL2 staining, leading to the conclusion that monocyte-EC contact induces CCL2 up-
regulation.  In our study of monocyte interaction with stimulated ECs, similar levels of 
CCL2 up-regulation were seen in monocytes that had directly contacted the ECs and in 
monocytes incubated beneath the ECs.  This indicates that there are at least two distinct 
mechanisms responsible for regulating CCL2 expression in monocytes incubated with 
either naïve or IL1β-stimulated ECs.   
 
Both CCL2 and CCL7 belong to the immune system response functional group (Table 8).  
Up-regulation of genes within this group may be mediated by a number of cytokines 
secreted by IL1β-stimulated ECs, including IL6 and fractalkine 80,89,90.  Except for 
interleukin receptor antagonist (IL1RN), increased expression of each of these genes 
would lead to increased accumulation of monocytes and other leukocytes within the 
tissue space during the acute cellular response phase of inflammation.  Up-regulation of 
IL1RN, which inhibits the cellular response to IL1β, may provide a mechanism for 
limiting long term monocyte recruitment to sites of inflammation 91.  In addition to the 
immune system response, EC secretions induced expression of genes involved in cellular 
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component organization and signal transduction.  EC secretions also down-regulated 
signal transduction genes and genes involved in the regulation of transcription (Table 9). 
 
Monocyte-endothelial contact leads to up-regulation of genes involved in signal 
transduction and the immune response (Figure 14C).  Among these genes, increased 
expression of cytokines and cytokine receptors such as chemokine (C-C motif) receptor 1 
92, formyl peptide receptor-like 1 93, and pre-B-cell colony enhancing factor 94 may 
enhance monocyte recruitment to sites of inflammation (Table 10).  Monocyte-
endothelial contact led to decreased expression of genes involved in lipid metabolism.  In 
particular, both phospholipase A2, group 3 (PLA2G3) and phospholipase A2, group 4A 
(PLA2G4A), enzymes involved in production of arachidonic acid, were downregulated 
by monocyte-EC contact.  Mishra et al. recently showed that knockdown of PLA2G4A 
expression leads to a reduction in the rate of monocyte chemotaxis towards CCL2 95.  
Down-regulation of these genes may play an important role in regulating monocyte 
transmigration and preventing long term monocyte accumulation within sites of 
inflammation.   
 
Diapedesis induces expression of a number of genes involved in cell differentiation 
(Figure 14D).  We initially hypothesized that monocyte transmigration might drive 
differentiation towards a macrophage or dendritic cell phenotype.  However, in our study 
genes that are up-regulated by diapedesis and related to cell differentiation are not 
specific to monocyte differentiation.  Recently, Lehtonenen et al. examined the gene 
expression of monocytes during the late and early stages of macrophage and dendritic 
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cell differentiation 96.  Comparison of our microarray data to genes differentially 
expressed in that study reveals that less than five percent of the genes differentially 
expressed in early macrophage or dendritic cell differentiation were differentially 
expressed in transmigrated monocytes.  None of the common cell surface markers for 
macrophages (CD14, FcgR1A, CD163) or dendritic cells (CD1a, CD1e, FceR1A/R2, 
CD1c, CD1b, LY75, CD209) were up-regulated at the mRNA level in our study, while 
Lehtonen et al. saw up-regulation of mRNA expression for all of these genes at late 
stages of macrophage and dendritic cell differentiation.  These data indicate that 
additional stimulation beyond transmigration is required for monocyte differentiation into 
macrophage or dendritic cell phenotypes.  This finding is supported by the seminal study 
of Randolph et al. which examined monocyte differentiation into dendritic cells after a 48 
hour incubation period in which monocytes transmigrated and then reverse-transmigrated 
back to the apical side of ECs grown on a collagen matrix 97.  This work showed that 
monocyte reverse-transmigration initiates differentiation of monocytes to dendritic cells; 
but, further stimulation is required for full differentiation to a mature dendritic cell 
phenotype.  In our study differentially regulated genes which are involved in cell 
differentiation may play an important role in mediating longer term monocyte 
differentiation in response to transmigration and other extracellular stimuli.   
 
Interestingly, our microarray data revealed that diapedesis leads to down-regulation of 
anti-microbial proteins (DEFA3, CAMP, CTSG, LTF).  These anti-microbial proteins act 
as an important non-oxidative mechanism of bacterial killing in phagocytic cells 98.  qRT-
PCR confirmed our microarray results for each of these proteins.  Immunoblots of α-
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defensin expression were used to confirm that down-regulation of these genes extends to 
the protein level.  In addition to bacterial killing, anti-microbial proteins have a number 
of inflammatory effects such as increased leukocyte chemotaxis 99, increased LDL 
accumulation within the endothelium and interference with vascular smooth muscle cell 
function 100.  Thus, it is possible that down-regulation of these proteins following 
transmigration may occur as a cytoprotective effect in order to maintain endothelial 
homeostasis and limit monocyte recruitment.   
 
Another possible interpretation of our data is that the monocytes which have higher 
expression levels of anti-microbial proteins are less efficient in transmigrating.  In our 
experimental setup it is impossible to rule out the possibility that the transmigrated 
monocytes represent a distinct population of monocytes which have an increased capacity 
for transmigration.  However, if so, this population would represent a previously 
undescribed phenotype comprising approximately 25% of monocytes, a large proportion 
compared with the largest known subpopulation, CD16+, which represent only 13 
percent of all human monocytes101.  Thus, it is our opinion that a more likely explanation 
is that diapedesis and monocyte-EC contact cause the observed changes in gene and 
protein expression rather than separation of high and low anti-microbial-expressing 
monocytes based on transmigration. 
 
In this study we have shown that freshly isolated human monocytes have decreased levels 
of apoptosis following transmigration across stimulated ECs.  We have also examined the 
effects of monocyte exposure to EC secretions, monocyte-EC contact, and diapedesis.  
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This data indicates that monocytes respond to EC secretions with increased production of 
cytokines, and other inflammatory genes.  Monocyte-EC contact also impacted 
inflammatory gene expression with increased expression of cytokines and cytokine 
receptors.  Finally, diapedesis led to differential expression of genes involved in cell 
differentiation and bacterial killing.  These changes in monocyte gene expression likely 
serve to prime monocytes for further downstream functions and differentiation outside 
the bloodstream.   Additionally, many of the differentially expressed genes play a role in 
either mediating or resolving inflammation.  Because numerous pathologies, such as 
arthritis and atherosclerosis, result from chronic inflammation, it is especially important 
that in monocyte transmigration a careful balance is maintained between inflammatory 




CHAPTER 4:  REVERSING SHEAR STRESS PROMOTES A MORE 
INFLAMMATORY AND PROLIFERATIVE PHENOTYPE IN ENDOTHELIAL 




N.B.  Work in this chapter was generated as a joint project with Daniel Conway, a fellow 
graduate student in the McIntire Lab.  I was responsible for the microarray analysis and 
participated jointly with Daniel in the design of the reversing shear stress system and 
performance of the monocyte adhesion assay.  Daniel performed the flow validation, 
shear stress experiments, and BrdU cell proliferation assays. 
 
Atherosclerosis is typically localized to the carotid artery sinus, the coronary arteries, the 
abdominal aorta, and the superficial femoral arteries 102.  These regions have complex 
blood flow patterns which include flow reversal during each cardiac cycle, leading to the 
hypothesis that disturbed hemodynamic patterns are atherogenic.  Such differences in 
hemodynamics alter the gene expression profile and ultimately the structure and function 
of endothelial cells, resulting in modulation of both endothelial cell responses to blood 
borne factors and endothelial cell interactions with underlying smooth muscle cells, thus 
increasing the likelihood of atherogenesis 103,104.   
 
Some of the earliest studies comparing “anti-atherogenic” non-reversing arterial shear 
stress to “pro-atherogenic” reversing arterial shear stress modeled the reversing shear 
stress in the form of a sine wave.  However, simulations of the wall shear stress of the 
carotid sinus have shown the wall shear stress is not harmonic, but is a more complex 
waveform 27,105.  This waveform has a low average shear stress of ~1 dyne/cm2 with peak 
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shear stresses as high as +/- 11 dyne/cm2.  Previous studies used high steady shear stress 
and static conditions as controls for comparison to the proatherogenic waveform 25,27,106.  
These studies did not address whether the low average shear stress or the flow reversal 
found at the wall of the carotid sinus was responsible for observed increases in 
atherogenesis.   
 
To address the limitations of previous studies, we developed a parallel plate reversing 
flow system that accurately recreates the physiological form of the reversing shear stress 
at the carotid sinus wall.  Using human umbilical vein endothelial cells, we compared the 
effects of this shear profile to the effects of steady arterial shear stress (15 dynes/cm2).  
Based on our previous work showing few differences between non-reversing pulsatile 
and steady shear stress 26,107, we chose a steady shear stress of 15 dynes/cm2 to 
approximate shear stress in the arteries.  We also included a steady low shear stress 
control (1 dyne/cm2) to distinguish gene and functional changes that were due to the 
application of a low average shear stress.  Functional analysis confirmed previous 
findings that reversing shear stress increases cell proliferation and monocyte adhesion; 
increased cell proliferation was found to be dependent on low average shear stress 
whereas monocyte adhesion was found to be dependent on fluid reversal.  Microarray 
results indicate that although there are unique sets of genes controlled by both low 
average shear stress and by reversing flow, more genes were controlled by low average 
shear stress.  We propose that low-time average shear stress, and not fluid 




Materials and Methods 
Reversing Shear Stress System Design and Validation  
The shear stress profile used in this study (Figure 15) was based on a computer 
simulation of the wall shear stresses at the carotid bifurcation (time-average 1 dyne/cm2, 
maximum +11 dynes/cm2, minimum -11 dynes/cm2, 1 Hz) 105.  A custom flow system 
was designed to reproduce this waveform in a parallel plate flow system (Figure 16).  The 
flow profile was split into two separate waveforms:  the steady component of the 
waveform (-1 dyne/cm2) and the reversing component of the waveform which had a time-
averaged shear stress of 0 dynes/cm2.  A standard syringe pump (Harvard Apparatus 33 
Twin Syringe Pump) was used to apply the continuous shear stress component.  A 1 mL 
glass syringe (Becton Dickinson) was mounted to a linear motor (MX80L, Parker 
Motion).  The linear motor controller (ACR9000, Parker Motion) was programmed to 
deliver the reversing flow component.   
 
Figure 15:   Wall shear stress of the carotid sinus used in the reversing flow system. 
A previously published computer simulation105 of the wall shear stress at the carotid sinus.  This shear 






Figure 16:   Schematic of the reversing flow system. 
 
To validate the reversing flow system, latex beads (6 μm, Bangs Laboratory) were 
tracked (Metamorph, Molecular Devices) under high-speed video microscopy (1000 
frames per second, (Phantom V4.2, Vision Research) to directly measure the flow rate 
through the chamber.  The focal plane of the microscope was selected to be the center of 
the parallel plate flow chamber and the velocity of the beads was assumed to represent 
the maximum velocity through the chamber.  Wall shear stress was calculated using 
Equation 1 (the average velocity was assumed to be two-thirds of the maximal velocity 





=     Equation 1 




HUVEC (passages 3-5) were grown to confluence on glass slides 26, mounted on a 
parallel plate flow chamber, and exposed to one of four conditions for 24 hours:  
reversing flow using the newly designed system (RF, 1 dyne/cm2 +/- 11 dyne/cm2), 
arterial high steady shear stress (HSS, 15 dynes/cm2), low steady shear stress (LSS, 1 
dyne/cm2), and static treatment.  RNA and protein were isolated using TRIzol.    
Microarray analysis was performed on RNA samples (Whole Human Genome arrays, 
Agilent).   
 
RNA and protein isolation 
Immediately after exposure to shear stress total RNA and protein were extracted using 
TRI-zol (Invitrogen); RNA was further purified with DNase (Qiagen) and RNeasy 
MinElute Cleanup Kit (Qiagen), according to manufacturers’ instructions. The integrity 
and quantity of the RNA were verified with UV spectrophotometry, accepting only RNA 
with a 260/280 ratio greater than 1.9. Protein concentration was quantified with DC 
Protein Assay (Bio-Rad) using bovine serum albumin standards. 
 
Microarray processing 
Microarray hybridization and imaging were performed at the Morehouse School of 
Medicine Functional Genomics Core Facility.  Briefly, RNA was linearly amplified to 
cRNA using Cy3 labeled CTP and a Low RNA Input Fluorescent Linear Amplification 
Kit (Agilent) according to the manufacturer’s instructions.  Cy3-labeled cRNA for each 
sample was hybridized to a 44k Whole Human Genome Microarray (Agilent) according 
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to the manufacturer’s instructions.  Slides were dried under nitrogen and scanned on an 
Agilent DNA Microarray Scanner.   
 
Microarray analysis 
Microarray images were analyzed with Agilent Feature Extraction Software according to 
the manufacturer’s instructions.  Genes were flagged as either present, marginal, or 
absent based on criteria such as image saturation, uniformity, population outlier, and 
uniformity of background.  GeneSpring GX 10 software was used to further analyze the 
microarray data.  One way ANOVA assuming equal variances was applied followed by a 
post-hoc Student-Neuman-Keuls test with a false discovery rate of 5%.  Differentially 
expressed genes were identified as those genes having adjusted p-values of less than 0.05 
and flags marked as present or marginal in at least 50% of the samples for conditions 
with fold changes of at least 1.5 fold.   
 
qRT-PCR 
Total RNA from each sample was reverse transcribed into cDNA using SuperScript II 
(Invitrogen).  cDNA was purified with Micro Bio-Spin P-30 Chromatography Columns 
(BioRad), and diluted in RT-PCR Grade Water (Ambion).  Pre-designed PCR primers 
and Quantitect SYBR Green PCR Master Mix were purchased from Qiagen.  Primers 
were added to the master mix at a ratio of 1:5.  Each reaction was performed with 4 μl of 
diluted cDNA and 6 μl of primers in the master mix.  The qRT-PCR reactions were 
performed on a MyIQ (BioRad) with a 15 minute activation step at 95 oC; 50 cycles at 94 
oC for 15 seconds, 55 oC for 30 seconds, 72 oC for 30 seconds; and a ramped melting 
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cycle.  Fold changes were determined using the ΔΔCt method.  qRT-PCR was used to 
verify gene expression from RNA isolated from five independent experiments.   
 
Cell Proliferation Assays 
To measure changes in cell proliferation, shear stress experiments were performed in the 
presence of 10 μM bromodeoxyuridine (BrdU) (EMD Biosciences).  Cells were fixed in 
4% paraformaldehyde, treated with 2N HCl and 0.1% Triton-X, stained using a rat anti-
BrdU antibody (Abcam), and finally stained with goat anti-rat Alexa Fluor 563 
(Invitrogen) and Hoechst (Invitrogen).  Standard fluorescent microscopy was used to 
image the cells.  ImageJ (NIH) was used to count BrdU stained cells and Hoechst stained 
cells in each frame.  For each experimental condition 8 frames were analyzed for each 
experimental replicate with a total of 5 replicates. The percentage of cells that divided 
under shear stress was determined by dividing the BrdU positive cells by the total number 
of cells as measured by the Hoechst staining.   
 
Monocyte Adhesion Assays 
Monocyte adhesion assays were performed on HUVEC pretreated for 24 hours with one 
of the four shear stress conditions.  Cell tracker orange stained THP-1 (Human acute 
monocytic leukemia cell line) cells (106 cells/mL) were perfused across the pretreated 
HUVEC at 1 dyne/cm2 for 5 minutes, stopping the flow for 30 seconds, and rinsing with 
media for an additional 5 minutes.  The number of adherent cells was then counted in ten 





High-speed video tracking of latex beads through the parallel plate chamber allowed for 
measurement of the average flow rate and the calculation of the wall shear stress in the 
chamber.  Figure 17 provides a visual comparison of the wall shear stress within our 
parallel plate flow chamber to the in vivo shear stress at the wall of the carotid sinus as 
determined by computer simulations performed by Perktold and Rappitsch105.  This 
comparison shows that our system accurately recreates the in vivo reversing shear stress 
found at the wall of the carotid sinus.  Because this area of the vasculature is particularly 
prone to atherosclerosis, validation of our system’s ability to model flow within the 
carotid sinus indicates that our system is appropriate for studying the effects of this 
altered flow type on endothelial cells.   
 























Figure 17:  Comparison of in vitro parallel plate shear stress to in vivo shear stress. 
In vitro parallel plate shear stress was estimated by tracking latex beads within the flow chamber using 
high speed video microscopy.  In vivo shear stress was estimated by Perktold and Rappitsch using 




ECs treated with steady shear stress of 15 dyne/cm2 for 24 hours aligned parallel to the 
flow direction (Figure 18). ECs exposed to 1 dyne/cm2 were randomly aligned and 
slightly elongated in comparison to static conditions.  Under reversing flow, the cells 
exhibited a cobblestone morphology which is quite similar to that seen under static 
conditions.   
Reversing flow 15 dynes/cm2
Static 1 dyne/cm2
 
Figure 18:  Variations in fluid flow patterns cause altered EC morphology. 
Phase contrast images of ECs exposed to 15 dynes/cm2 shear stress for 24 h reveal an elongated 
morphology which is aligned with shear stress.  ECs exposed to 1 dyne/cm2  have an elongated morphology 
but do not align with shear stress.  ECs exposed to reversing flow exhibit a cobblestone like morphology 







A comparison of HUVEC exposed to 24 hours of reversing flow (RF), high steady shear 
(HSS), low steady shear (LSS), and static culture (STAT) was performed with a whole 
human genome microarray.  One way ANOVA with a false discovery rate of 5% 
revealed 4767 genes with statistically significant differences between at least two of the 
treatment conditions.  A post hoc Student-Newman-Keuls test was performed to 
determine which conditions were significantly different from each other for each gene.  
Differentially expressed genes were identified as those that passed the Student-Newman-
Keuls test and had flags present or marginal in at least 50% of the samples for conditions 
having greater than 1.5 fold changes in expression between at least two of the four 
HUVEC treatment conditions.  A total of 4017 differentially expressed genes were 
identified.  Table 12 contains the number of differentially expressed genes between each 
condition.  (See Supplemental Table 8 for lists of gene names and fold changes 
associated with each of these comparisons.)   
Table 12:  Number of Differentially Expressed Genes Between Conditions 
 Static HSS LSS 
HSS 3,026 -- -- 
LSS 2,998 194 -- 
RF 3,102 365 57 
 
ECs exposed to fluid flow differentially expressed ~3000 genes as compared to ECs 
exposed to static conditions.  This high number of differentially expressed genes 
compared to static was independent of the type of fluid flow that ECs were exposed to.  
On the other hand, a comparison of gene expression between fluid flow types revealed 
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that the largest number of differentially expressed genes can be found in a comparison of 
reversing flow to high shear stress, with 365 differentially expressed genes.  When 
reversing flow was compared to low shear stress, less than 100 genes were found to be 
differentially expressed.   
 
Differentially expressed genes for each of the 3 flow conditions compared to static are 
shown on the proportional Venn diagram in Figure 19 108.  57 % of the total number of 
genes found in these three comparisons are differentially expressed in all of the shear 
stress conditions.  Further examination of these genes shows that there is 100% 
agreement for all of the flow conditions in the direction of differential expression as 
compared to static.  This indicates that exposure to shear stress determines whether these 
genes will be up- or down-regulated as compared to the static condition.  Thus, the type 
of shear stress that ECs are exposed to regulates the value of the fold change rather than 
the direction of the fold change that occurs when comparing gene expression in shear 
stress conditions to static conditions.  Table 13 contains a list of twenty genes which are 




Figure 19:  Proportional Venn diagram of differentially expressed genes in a comparison of RF, HSS, 
and LSS to static culture.   
Genes found within the white area of the Venn diagram are differentially expressed by all three fluid flow 











(Flow vs Static) 
GPR83 G protein-coupled receptor 83 57.2 
CYP1B1 Cytochrome P450, family 1, subfamily B, polypeptide 1 54.1 
KCNK3 Potassium channel, subfamily K, member 3 39.8 
IL11 Interleukin-11 22.4 
ID2 Inhibitor of DNA binding 2 20.8 
FREM3 FRAS1 related extracellular maxtrix 3 20.6 
GLI2 GLI-Kruppel family member 2 18.3 
SAMD11 Sterile alpha motif domain containing 11 17.8 
AKR1C1 Aldo-keto reductase family member 1C 16.9 
SMAD7 SMAD family member 7 16.6 
CD34 CD34 molecule -32.7 
XLKD1 Extracellular link domain containing 1 -38.0 
PPP1R9A Protein phosphatase 1 regulatory subunit 9A -42.0 
PRND Prion protein 2 -50.3 
CHRNA1 Cholinergic receptor nicotinic alpha 1 -50.5 
DHRS3 Dehydrogenase/reductase (SDRfamily) member 3 -62.4 
CYP26B1 Cytochrome P450, family 26, subfamily B, polypeptide 1 -68.0 
KIT v-kit Hardy Zuckerman 4 feline sarcoma viral oncogene homolog -76.0 
MYO5C Myosin VC -89.9 
C10Orf10 Chromosome 10 Open reading frame 10 -143.1 
*Fold changes represent the average of the average fold change in comparison to static for reversing flow, 
high shear stress, and low shear stress. 
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Hierarchical clustering applied to the four EC culture conditions provides further 
evidence that the largest differences in gene expression are seen between ECs exposed to 
fluid flow of any type and ECs grown under static conditions.  Figure 20 reveals that HSS, 
LSS, and RF cluster on a branch separate from static culture.  From there HSS and LSS 
cluster separately from RF, indicating that ECs exposed to high shear stress or low shear 
stress are more similar to each other in terms of gene expression than ECs exposed to 
reversing flow. 
 
Figure 20:  ECs exposed to fluid flow cluster on a branch separate from ECs grown in static culture. 
 
 
In Table 12, the greatest number of differentially expressed genes is found in a 
comparison of RF and HSS, with 365 differentially expressed genes.  Comparison of 
HSS to LSS showed 194 genes were differentially expressed, while only 57 genes were 
differentially expressed when RF and LSS were compared.  These differences in the 
number of differentially expressed genes are indicative of the large changes in EC 
phenotype that can be found between ECs growing on the wall of the carotid sinus and 
ECs located in other regions of the vasculature which do not experience blood flow 
disturbances caused by curvature of the vessels or branching.  The Venn diagram shown 




Figure 21:  Venn diagram of differentially expressed genes in a comparison of RF to HSS, RF to LSS, 
and HSS to LSS. 
Differentially expressed genes found in the purple region of overlap are regulated by low average flow 
while genes found within the yellow region of overlap are regulated by flow reversal.  Genes located within 
the light blue area are regulated by high average shear stress.   
 
In our study there are two conditions which have low average shear stress, LSS and RF.  
Examination of the purple portion of Figure 21 shows that when either LSS or RF is 
compared to HSS there are 138 genes that are found in both lists.  Further examination 
shows that in all of these genes both LSS and RF generate the same direction of either 
up- or down-regulation compared to HSS.  Based on this similar response to both LSS 
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and RF as compared to HSS, these genes can be termed "regulated by low average shear 
stress" (Supplemental Table 9, list of genes with fold changes).  DAVID functional 
annotation clustering was used to group down-regulated and up-regulated genes based on 
function.  These functional groups are shown in Figure 22 and Figure 23 as hierarchical 
clusters of associated genes and conditions. 
 
These hierarchical clusters include down-regulation by low average shear stress of genes 
associated with anatomical structure development, cell communication, response to 
external stimuli, blood vessel morphogenesis, chemical homeostasis, hydrolase activity, 
and actin filament organization (Figure 22).  Genes up-regulated by low average shear 
stress were associated with metallothioneins and cell cycle phase (Figure 23).   
 
These hierarchical clusters show clustering of both genes and conditions associated with 
functional groups regulated by low average shear stress.  In all of the hierarchical clusters 
shown, ECs exposed to reversing flow and ECs exposed to low shear stress cluster on a 
branch which is separate from ECs exposed to high shear stress.  It should be noted that 
clustering of the reversing flow and low shear stress conditions on a single branch is in 
contrast to the clustering results obtained when all of the genes on the microarray were 
incorporated into the clustering algorithm.  This is a further indication that these genes 










































































































































































Figure 23:  Hierarchical clusters of functional groups up-regulated by low average shear stress.   
Flow conditions and genes associated with functional groups identified by DAVID were clustered 
according to expression patterns.  The color range shown is indicative of the normalized natural log 
transformed signal values for each gene. 
 
In our study RF was compared to both HSS and LSS.  The yellow portion of Figure 21 
shows that there are 22 genes which overlap between these two comparisons.  100% of 
the genes showed similar directions of up-or down-regulation in response to reversing 
flow as compared to both HSS and LSS.  Based on this these genes can be termed 
"regulated by reversing flow" (Table 14).  DAVID functional annotation clustering was 
used to group these genes based on function.  Differentially regulated functional groups 
are shown in Figure 24 as hierarchical clusters of associated genes and conditions.  In 
these hierarchical clusters, ECs exposed to reversing flow clustered on a branch separate 
from ECs exposed to high shear stress or low shear stress.  This pattern coincides with 
the clustering results obtained from analysis of the entire array as shown in Figure 20.  
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Table 14:  Genes regulated by flow reversal 
Gene Symbol Gene Name Fold Change 
(RF/HSS) 
   
AK023086 Unannotated 3.1 
GGTLA1 gamma-glutamyltransferase-like activity 1 2.5 
PRIM2A primase, polypeptide 2A 2.5 
FLJ14712 Unannotated 2.4 
CCNE2 cyclin E2 2.4 
CEP55 centrosomal protein 55kDa 2.1 
APOM apolipoprotein M 1.9 
RRM1 ribonucleotide reductase M1 polypeptide 1.9 
KRTAP19-1 keratin associated protein 19-1 1.8 
ATAD5 ATPase family, AAA domain containing 5 1.8 
PIF1 PIF1 5'-to-3' DNA helicase homolog  1.8 
KIF21A kinesin family member 21A 1.8 
BC020241 Unannotated 1.8 
C21orf2 chromosome 21 open reading frame 2 1.7 
CASC5 cancer susceptibility candidate 5 1.7 
JPH2 junctophilin 2 1.7 
PRKACB protein kinase, cAMP-dependent, catalytic, beta (PRKACB), 
transcript variant 3, mRNA [NM_207578] 
1.6 
BC017350 Unannotated -1.6 
CDC42EP3 CDC42 effector protein (Rho GTPase binding) 3 -1.8 
SLC26A2 solute carrier family 26 (sulfate transporter), member 2 -1.8 
THC2722466 Unannotated -1.9 






Figure 24:  Hierarchical clusters of functional groups regulated by reversing flow.   
Flow conditions and genes associated with functional groups identified by DAVID were clustered 
according to expression patterns.  The color range shown is indicative of the normalized natural log 
transformed signal values for each gene. 
 
Further examination of Figure 21 shows that in the light blue section there are 5 genes 
which overlap.  This portion of the Venn diagram represents genes which are 
differentially expressed in a comparison of HSS to LSS and RF to LSS.  In this case both 
HSS and RF have been exposed to high shear stresses for at least some period of time 
during each cycle.  As with the other genes in overlapping lists described previously, 
exposure to HSS and RF induced differential expression compared to LSS in the same 
direction of either up- or down-regulation.  Thus, these 5 genes may be regulated by 
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exposure to high shear stress despite the fact that the average shear stress applied to RF is 
low.   
 
qRT-PCR 
Microarray data was confirmed with qRT-PCR on two genes up-regulated by low 
average shear stress, metallothionein 1F (MT1F) and cyclin B3 (CCNB3), along with two 
genes down-regulated by low average shear stress, Kruppel-like factor 2 (KLF2) and 
natriuretic peptide receptor A (NPR1).  Additionally, two genes up-regulated by 
reversing flow, primase polypeptide 2A (PRIM2A) and cyclin E2 (CCNE2), were chosen 
for qRT-PCR confirmation.  Comparisons of qRT-PCR data and microarray data are 
shown in Figure 25.  The genes regulated by low average shear stress had very similar 
changes in expression as measured by either qRT-PCR or microarray.  Of the two genes 
which were up-regulated by reversing flow, only PRIM2A had qRT-PCR data similar to 
microarray data.  CCNE2 showed no significant change in expression between the three 
flow conditions when measured by qRT-PCR.   
 
Cell Proliferation 
To further investigate cell cycle changes, cells exposed to either static culture, HSS, LSS, 
or RF were assayed for cell proliferation via incubation with BrdU followed by staining 
for BrdU incorporation into the DNA.  Although static control cultures had the greatest 
fraction of BrdU positive cells, comparisons among the shear stress conditions showed 
that the number of BrdU positive cells was increased over two-fold under reversing shear 





Figure 25:  qRT-PCR Confirmation of Microarray Results 
Four genes regulated by low average shear stress and two genes regulated by reversing flow were chosen 
for confirmation of microarray results with qRT-PCR.  Blue bars are microarray data and red bars are qRT-





Figure 26:  Cell proliferation is inhibited by high shear stress compared to low average shear stress. 
ECs were stained for BrdU incorporation (red) and the presence of nuclear DNA using Hoechst 33258  
(blue) following culture in either static or flow conditions.  Nuclei appearing pink are indicative of positive 
staining for both DNA and BrdU.  (A) A representative image of ECs cultured at 15 dynes/cm2 for 24 hours 
and stained for BrdU incorporation and nuclear DNA.  (B)  A representative image of ECs cultured under 
reversing shear stress for 24 hours and stained for BrdU incorporation and nuclear DNA.  (C)  Fluid flow 
caused a reduction in BrdU incorporation.  Exposure to high shear stress caused the greatest reduction in 
BrdU incorporation.  The percentage of nuclei which stained positively for BrdU was determined by 




that exposure of ECs to shear stress causes inhibition of cell proliferation.  In comparison 
to HSS, both RF and LSS cause increased cell proliferation in ECs, indicating that low 
time average shear stress is involved in regulating cell division. 
 
Monocyte Adhesion 
To assess the ability of reversing shear stress to lead to increased inflammation and 
leukocyte recruitment, a monocyte adhesion assay was performed on HUVEC pretreated 
with all shear stress conditions.  Significantly increased monocyte adhesion was observed 
under reversing flow, but not under other conditions (Figure 27).   
 
THP-1 Cell Adhesion






















Figure 27 THP-1 cells have greater adhesion to ECs exposed to reversing flow. 
THP-1 cells were counted in 10 frames each of five to six separate experiments.  Dots shown on the graph 
represent the average number of adherent cells in each experiment.  The line shown on the graph represents 





We describe herein the design and application of a novel reversing shear stress system 
using a parallel plate flow chamber.  Other studies have used a variety of parallel plate or 
cone and plate systems to study the effects of either disturbed or oscillating flow on 
endothelial cell gene expression25,27,106,109-111.  Some of these studies comparing the 
effects of steady shear stress to reversing shear stress have modeled the reversing shear 
stress waveform as an oscillating sine wave function.  While this is a simpler shear stress 
to implement in an in vitro system, the physiological shear stress is not harmonic, and 
includes much more rapid changes in shear stress direction.  Also, the time-average shear 
stress in some models was set at zero,110 and as a result there was no net forward 
movement across the cells, a situation that does not occur in vivo.  Another limiting factor 
of previous studies is the lack of a steady low shear stress control, which would allow for 
differentiation of responses that are due only to time-average low shear stress from those 
due to fluid shear stress reversal.   
 
The shear stress profile chosen for our system was based on computer simulated data of 
the shear stress at the carotid sinus105 and is similar to that of the atheroprone waveform 
developed by Dai, et al.27.  However, unlike the system by Dai, et al., we designed our 
system to use a parallel plate chamber instead of a cone and plate.  A parallel plate 
chamber allowed us to perform a flow-based monocyte adhesion assay on cells pre-
treated with different shear stress conditions.  Although we have chosen to use this 
system to model the reversing shear stress at the carotid sinus, the linear motor can be 




With this system we investigated changes in cell morphology, gene expression, cell 
proliferation, and monocyte adhesion under reversing flow as compared to high shear 
stress, low shear stress, and static culture.  ECs exposed to reversing flow exhibited a 
cobblestone like appearance in contrast to ECs exposed to high shear stress which were 
elongated and aligned with flow.  Similar differences in cell morphology are seen in vivo 
when comparing porcine ECs found in the descending thoracic aorta (undisturbed 
unidirectional flow) and porcine ECs found adjacent to a branch of the aorta (separated 
disturbed flow)112, providing further evidence that our reversing flow system mimics in 
vivo fluid flow disturbances found in branching regions of the vasculature. 
 
In our system, fluid flow induced differential gene expression in approximately 7% of all 
human genes.  This number of differentially expressed genes is similar to, although 
slightly higher, than previous reports which indicate that shear stress affects between 1% 
and 6% of genes23,25,106,111,113.  Differences in the number of genes reported as 
differentially expressed can be attributed to microarray analysis techniques, microarray 
platforms, and differences in experimental setup.  In our system a comparison of fluid 
flow to static flow revealed that 57% of differentially expressed genes were similarly up- 
or down-regulated by high shear stress, low shear stress, and reversing flow as compared 
to static flow.  This indicates that up- or down-regulation of these genes is controlled 
simply by the presence of flow while the type of flow determines the magnitude of 
response rather than the direction of response as compared to static culture.  This is 
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further validated in Figure 20 by clustering of the three flow conditions on a branch 
separate from static culture.   
 
In order to validate our microarray data, we have compared our data to data from other 
groups who have looked at a comparison of endothelial cell gene expression under shear 
stress and static culture.  Our data comparing high shear stress to static culture confirmed 
72 percent of the genes reported by Ohura et al. to be up-regulated in HUVEC by 15 
dynes/cm2 laminar shear stress as compared to static culture106.  McCormick et al. 
reported transcriptional changes in HUVEC exposed to 25 dynes/cm2.  Our data 
confirmed differential expression for 47 percent of the genes reported by McCormick et 
al. which had fold changes of at least 1.5 fold at 24 hours23.  This agreement of our data 
with previously published reports on steady shear stress provides further validation of our 
microarray results. 
 
Comparisons of ECs exposed to different fluid flow regimes are more relevant to 
understanding vascular pathologies than comparison to static culture because static 
culture is not representative of a known physiological state.  Therefore gene expression of 
ECs exposed to reversing flow, high steady shear stress, and low steady shear stress were 
compared.  Comparison of reversing flow to high steady shear stress identified 365 
differentially expressed genes between the two conditions.  The reversing flow profile 
which we used has a low time averaged shear stress of approximately 1 dyne/cm2.  
Therefore, further comparisons were performed to determine whether differential gene 
expression was induced by low average shear stress or flow reversal.  138 genes were 
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identified as being regulated by low average shear stress, while only 22 genes were 
identified as being regulated by flow reversal. 
 
Flow reversal caused up-regulation of three genes related to DNA replication (Figure 24).  
RRM1 is a gene which encodes for one of two subunits that make up ribonucleotide 
diphosphate reductase, an enzyme required for the production of deoxyribonucleotides 
prior to DNA synthesis114.  CCNE2 encodes for cyclin E2 which regulates CDK2 activity 
and is involved in the G1 to S phase transition115.  Finally, PRIM2A is responsible for 
synthesis of small RNA primers necessary for Okazaki fragments made during DNA 
replication116.  Up-regulation of these genes by flow reversal may play an important role 
in regulating cell proliferation.   
 
The reversing flow profile which we have studied is similar to the “athero-prone” 
waveform studied by Dai et al27.  This group used a cone and plate device to apply either 
athero-prone reversing flow or athero-protective pulsatile non-reversing flow to ECs.  
This group found 159 genes which were differentially regulated in a comparison of ECs 
exposed to either athero-prone or athero-protective flow profiles.  In our system a 
comparison of reversing flow to high steady shear stress revealed differential regulation 
of 13 of these same genes.  Our data further reveals that 10 of these 13 genes are 
regulated by low average shear stress rather than flow reversal (APOL3, CD34, CD58, 




Our lab has recently further examined CYP1B1 expression and confirmed regulation of 
CYP1B1 by low average shear stress 117.  KLF2 has been shown to be attenuated under 
reversing shear stress as compared to non-reversing shear stress27;  however, other 
published work has shown KLF2 is also equally attenuated under low shear stress118,119 
supporting our observation that KLF2 is regulated by low average shear stress.  
Regulation of metallothioneins was also reported by Ohura et al. who examined the 
effects of turbulent flow in comparison to high steady laminar flow 106; however, in their 
system turbulent flow caused down-regulation of metallothionein expression while in our 
system reversing shear stress caused up-regulation of metallothioneins.  Our lab has also 
shown metallothioneins to be one of the few genes differentially regulated by non-
reversing pulsatile shear stress compared to steady shear stress.107  These differences 
indicate that metallothionein expression is highly sensitive to variations in endothelial 
shear stress, which may be important for regulation of downstream signaling events.   
 
Our results indicate that a number of genes which regulate the cell cycle are up-regulated 
by low average shear stress in comparison to high steady shear stress.  We performed an 
analysis of BrdU incorporation in order to assess the effects of differential expression of 
these genes on cell cycle progression.  The increased BrdU incorporation suggests that 
cell cycle progression can be up-regulated under reversing shear stress.  Interestingly 
similar results were observed for the low shear stress control, suggesting that the time-




We also observed increased monocyte adhesion to ECs following exposure to reversing 
shear stress.  This increase in monocyte adhesion was not found in ECs following 
exposure to low steady shear stress, indicating that fluid reversal is responsible for the 
development of a more adhesive and activated endothelial cell phenotype.  Previous 
studies of EC exposure to oscillatory flow have shown a similar increase in monocyte 
adhesion 109,110,120.  These studies examined monocyte adhesion following a 45 minute 
incubation with ECs exposed to oscillatory shear stress.  In our study we have examined 
monocyte adhesion under flow;  monocytes were perfused across ECs at 1 dyne/cm2 for 
five minutes and an assessment of monocyte rolling or firm adhesion revealed no binding 
between the flowing monocytes and the ECs.  However, when fluid flow was stopped for 
30 seconds and then returned to 1 dyne/cm2, monocytes firmly adhered to ECs exposed to 
reversing flow and did not firmly adhere to ECs grown in static culture or exposed to 
high or low steady shear stress.  These data indicate that flow reversal fails to induce 
expression of selectins or other molecules involved in initial leukocyte binding; however, 
exposure to reversing flow leads to increased firm adhesion likely mediated by integrin 
ligands such as ICAM1 and VCAM1.   
 
In summary we have developed a physiological reversing shear stress system which can 
be used to reproduce the wall shear stress at the carotid sinus.  Using a low steady shear 
stress control, we show that most gene expression changes in cells exposed to reversing 
shear stress are regulated by the low time average shear stress and not fluid shear stress 
reversal.  We also show that low time average shear stress is the major force responsible 
for increases in cell proliferation as compared to cells exposed to arterial levels of steady 
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shear stress.  Interestingly, we showed increased monocyte adhesion only in cells 
exposed to reversing shear stress.  Our findings provide further insight into endothelial 
responses to mechanical forces and may be important in understanding mechanisms of 









In this project, I have examined endothelial and leukocyte responses to inflammatory 
stimuli and leukocyte transmigration.  Key findings from each chapter are presented 
below. 
 
Chapter 2:  Gene expression of endothelial cells due to interleukin-1 beta stimulation and 
neutrophil transmigration 
• Identified over 2500 genes differentially expressed in HUVEC following IL1β 
stimulation 
• IL1β induced differential expression of genes related to apoptosis, cell cycle, 
NFκb cascade, chemotaxis, and the immune response 
• Claudin-1 mRNA and protein are up-regulated by IL1β 
• Occludin mRNA and claudin-5 mRNA and protein are down-regulated by IL1β 
• PBEF mRNA and protein are up-regulated following IL1β stimulation 
• Neutrophil transmigration had little impact on EC gene expression in comparison 






Chapter 3:  Transmigration across activated endothelium induces transcriptional 
changes in monocytes 
• Identified over 600 genes differentially expressed in transmigrated monocytes as 
compared to untreated monocytes 
• Transmigration induced differential expression of genes related to numerous cell 
functions including the immune response and inhibition of apoptosis 
• AnnexinV labeling showed reduced apoptosis in monocytes following 
transmigration 
• qRT-PCR confirmed increased expression of NAIP, an inhibitor of apoptosis, in 
monocytes following transmigration 
• Identified 89 genes regulated by the process of diapedesis 
• Confirmed down-regulation of antimicrobial mRNA and protein expression 
following monocyte transmigration 
 
Chapter 4:  Reversing shear stress promotes a more inflammatory and proliferativer 
phenotype in endothelial cells than steady shear stress 
• Developed a parallel plate flow system to accurately recreate the shear stress 
found at the wall of the carotid sinus 
• Identified ~3000 genes differentially expressed in ECs treated with shear stress as 
compared to static culture 
• Identified 138 genes regulated by exposure to low average shear stress 
• Genes regulated by low average shear stress are involved in cell cycle regulation, 
metallothioneins, cell communication, and anatomical structure development 
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• Identified 22 genes regulated by exposure to reversing flow which are involved in 
DNA replication and ATP binding 
• ECs exposed to low steady shear stress or reversing flow exhibited increased cell 
proliferation in comparison to ECs exposed to high steady shear stress 
• Increased monocyte adhesion on ECs exposed to reversing flow as compared to 
high steady shear stress, low steady shear stress, or static culture.   
 
Future Work 
This work has used microarray analysis in combination with other techniques to analyze 
leukocyte and endothelial responses to chemical and mechanical stimuli relevant to 
inflammation.  As with all research, this project has also revealed numerous questions 
which remained unanswered.  In Chapter 2 I showed up-regulation of claudin-1 and 
down-regulation of claudin-5 and occludin following treatment with IL1β.  These 
proteins are all found at cell-cell junctions between endothelial cells and are thought to 
play an important role in regulating endothelial permeability and transendothelial 
resistance.  It is clear that the endothelium maintains tight control over expression of 
these cell junction molecules and further studies are necessary to understand how they 
work together to regulate endothelial junctions during inflammation, particularly during 
transmigration.  In Chapter 2, I also showed up-regulation of PBEF which is a cytokine 
thought to be involved in leukocyte recruitment and regulation of the endothelial barrier.  
The importance of this protein for regulating the endothelium and leukocyte 
transmigration is not well understood and deserves further study.  Finally our work 
showed that neutrophil transmigration had little impact on EC transcription compared to 
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the large impact of IL1β stimulation.  However, recent studies have provided more 
evidence of EC intracellular responses to leukocyte transmigration and adhesion.  Thus 
while ECs do not appear to significantly alter transcriptional patterns in response to IL1β 
induced transmigration, they certainly undergo changes in cytoskeletal organization, 
adhesion molecule clustering, and activation of signal transduction pathways.  Further 
studies are necessary to gain a full understanding of how ECs respond to inflammatory 
processes. 
 
In Chapter 3 my work focused on monocyte responses to transmigration.  In this work I 
showed that monocytes have reduced apoptosis following transmigration.  In addition I 
showed that NAIP, a key inhibitor of apoptosis found within the apoptosis pathway, is 
up-regulated following transmigration.  This suggests that NAIP is involved in the 
inhibition of apoptosis following transmigration.  To further substantiate this, activity of 
caspase 3 and 9 should be examined.  More research is necessary in order to understand 
the mechanisms by which diapedesis causes up-regulation of NAIP expression.  My work 
also showed down-regulation of antimicrobial proteins following transmigration.  Further 
studies are necessary to determine whether the same response is seen in monocytes 
exposed to bacteria following transmigration.  In addition the respiratory burst and 
bacterial killing ability of transmigrated monocytes should be further examined. 
 
In Chapter 4 I examined the endothelial response to reversing flow.  Comparison to low 
and high shear stress controls revealed that a number of transcriptional changes are 
regulated by exposure to low average shear stress rather than flow reversal.  This data 
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also showed increased cell proliferation in ECs exposed to low average shear stress as 
compared to high steady shear stress.  Further studies are required to understand the 
mechanisms involved in regulating cell proliferation and leukocyte adhesion.   
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APPENDIX A:  CALCULATION OF WALL SHEAR STRESS  
 
 
The measurement of fluid shear stress was accomplished through the use of latex beads 
filmed under high speed video microscopy (1000 frames per second).  This appendix 
explains how the measured velocity of these individual beads was used to determine wall 
shear stress.   
 







































































The Navier-Stokes Equation can be simplified for the fluid flow through a parallel plate 
chamber based on the following assumptions: 


















vx    
3.  Laminar flow 
0=yv   0=zv  
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5.  No gravity in the x direction 
0=xpg  











∂ μ  
If the pressure drop is assumed to be constant over the entire length of the chamber, this 




































vx  at y = 0 and vx = 0 at y = b/2 
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LQP μ=Δ  
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Relationship between fluid velocity and shear stress 
 To focus the high speed video camera at the center of the flow chamber, a mark 
was made on the glass slide and also on the surface of the flow chamber.  The focus knob 
was marked at each position and then adjusted to the middle.  The velocity at the middle 
of the chamber (y=0) represents the maximum velocity, and the measured beads were 
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